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CHAPTER 1
INTRODUCTION
1.1 Natural Products
Natural products, obtained from plants, animals or micro-organism as secondary
metabolites have been implicated for a long time in the treatment and prevention of
human disease (Jiet al., 2009 and Lahlou Mouhssen 2013). In fact, some compounds may
be formed as a result of the "metabolic accident", or as a by-product of the synthesis
machinery of the cellular enzymes. Regardless of their utility to the parent organism,
their value to human as drugs, herbs, flavorings, poisons, dyes, and so has been found to
be invaluable.
History of medicine dates back practically to the existence of human civilization.
Historically, the majority of new drugs have been generated from natural products
(secondary metabolites) including the compounds derived from natural products (Ji et al.,
2009).
1.1.1 Definition of Natural Products
For an organic chemist, a natural product is a metabolite that is produced by a
living organism. This definition encompasses many compounds, such as carbohydrates,
proteins, lipids, and nucleic acids, possessing a primary role in the metabolic reactions.
However, there are other organic compounds produced naturally, with an extraordinary
complexity, which may not be primary metabolites. Organic chemists have always been
fascinated by the great diversity of these substances, and particularly those, which could
be isolated from plants or from microorganisms.
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1.1.2 History of Natural Products
Throughout history, humans have significantly benefitted from nature to cure
their ailments. According to some of the earliest recordings, natural product uses were
scripted on clay tablets found in Mesopotamia from around 2600 B.C. These tablets
documented the use of oil from Cupressus sempervirens (Cypress) and Commiphora
species (myrrh). Cypress and myrrh oils are still used today to treat respiratory
inflammation. During the Age of Pericles, the prominent Greek physician Hippocrates
(circa 460-370 BC) collected more than 400 natural products. Moreover, early recorded
work on these medicinal compounds and their uses can be found in their Corpus
Hippocraticum too (Dias et al., 2012). Similarly, other Greek physicians such as
Dioscorides, (100 A.D.), and Theophrastus (~300 B.C.) have also mentioned about the
whole process including collection, storage and practice of herbal medicine. Among old
record of Chinese pharmaceutical medicine are Chinese “Materia Medica’’ (1100 B.C.)
listing 52 herbal prescriptions, Tang Herbal (659 A.D.) documenting 850 drugs (Cragg, et
al., 2005).
Likewise, Chinese medicine documentation by Shennong Herbal (~100 B.C.,)
have exhibited the recording 365 drugs using dried parts of medicinally active plant
containing ginseng, camphor, cinnamon bark, ephedra, jimson weed etc. (Bottcher, 1965;
Wiart, 2006; Petrovska, 2012). An Egyptian record, The Ebers Papyrus (2900 B.C.)
documents therapy including 800 prescriptions over 700 plant-based drugs, and some of
the plant materials mentioned are aloe, garlic, onion, juniper, coriander, pomegranate and
castor oil (Glesinger, 1954; Tucakov, 1964).
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1.1.3 Traditional Medicine System
In developing and under developed countries of Asia, Africa and Latin America,
traditional medicine (TM) has been the primary source of health care since modern
medicines of allopathy are too expensive for them to afford. That’s the reason more than
80% people are dependent on traditional medicine based largely plants and animals for
their primary health care. However, in developed countries, including the wealthy class
has incorporated traditional medicine as a complementary or alternative medicine
(CAM). TM knowledge has recently grabbed worldwide attention in light of global
health care demand, and the significant role of traditional medicine in meeting the public
health needs of underdeveloped and developing countries. The World Health
Organization (WHO) defines traditional medicine as “Sum total of the knowledge, skills
and practices based on the theories, beliefs and experiences indigenous to different
cultures, whether explicable or not, used in the maintenance of health, as well as in the
prevention, diagnosis, improvement or treatment of physical and mental illnesses
(WHO/EDM/TRM/2000).
Practices of TM tend to be categorized by personal treatment, thereby putting the
emphasis on maximizing body’s inherent healing ability, patients’ personal care,
addressing physical, mental, and spiritual attributes of a disease, and hence places a
considerable emphasis on prevention and wellness (Abbott et al., 2011). TM practices
exhibit considerable diversity and can vary significantly with country and region, as they
are influenced by factors such as culture, history, personal attitudes and philosophy
(Husain et al., 2010).
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Traditional medicine is not only a vital source of health care, but has also served
as an important source of income. This economic activity supports many indigenous
peoples and local communities, a benefit that in turn provides incentives for the
conservation of TM. While some medicinal plants are cultivated commercially, most of
them are from wild (Srivastava et al., WTP 1996). Traditional medicine may even form
an integral part of a community’s identity. Traditional medicine also has contributed
substantially towards the development of pharmaceutical treatments, where as much as
one-third to one-half of pharmaceutical drugs was originally derived from plants (Barrett
et al., 1999).
Traditional medicine involves the use of herbal medicines, animal parts and
minerals. Most comprehensively used material are herbal medicines subsuming herbs,
herbal materials, herbal preparations and prepared herbal products containing active
ingredients parts of plants, or other plant materials, or combinations. Herbal medicines
are currently in demand and their popularity is in gradual rise, and about 500 plants with
medicinal usage are mentioned in ancient literature. Furthermore, around 800 plants have
been found to be used in indigenous systems of medicine (Verma et al., 2008).
The selection of plant material for curing and healing purpose was dependent on
ethno-botanical knowledge acquired by use of plant material (Rout et al., 2009).
Being a natural product drug discovery group member, our primary objective was
to study the herbal medicines containing active ingredients with therapeutic activity.
WHO has also issued Guidelines for the Assessment of Herbal Medicines (Srivastava et
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al., WTP 1996). These guidelines define the basic criteria for the evaluation of quality,
safety and efficacy of herbal medicines.
Practices of traditional medicine may profoundly vary geographically, as they are
influenced by factors such as culture, history, personal attitudes and philosophy. In many
cases, their theory and application are quite different from those of conventional
medicine. Long historical use of many practices of traditional medicine, including
experience passed on from generation to generation, has demonstrated the safety and
efficacy of traditional medicine. However, scientific research is needed to provide
additional evidence of its safety and efficacy. In conducting research and evaluating
traditional medicine, knowledge and experience obtained through the long history of
established practices should be respected.
Traditional medicine system comprises Scholarly Medical System such as Unani
System, Ayurveda, Homeopathy, Tibetan Medicine, Folk Medicine (Gewali et al., 2008).
1.1.4 Ayurveda
Ayurveda is a holistic healing science which comprises of two words, Ayu and
Veda. Ayu means life and Veda means knowledge or science. So the literal meaning of
the word Ayurveda is the science of life. Ayurveda is a science dealing not only with
treatment of some diseases but is a complete way of life. Its foundation comes from the
Vedic Era, the primitive age around 5000 years ago with historical roots in the Indian
subcontinent and practices more in countries like India and Nepal, and nowadays
distributed worldwide.
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According to early Vedic literature, Ayurveda was supposedly first passed on by
Lord Brahma to sage Bhardwaja. Bhardwaja in turn taught it to other sages and so on.
During long Practices different sages contributed in Ayurveda system to provide quality
of life by following certain principles to maintain healthy body and environment and to
cure diseases. The early texts on Ayurveda include the Charaka Samhita, the Sushruta
Samhita and the Bhela Samhita. Charaka Samhita was written by Sage Agnivesa around
(1500- 1000 BC) where a comprehensive work was later done by Charaka (300-200 BC)
and further updated by Dridhabala (400 AD). The Susruta samhita was written by Susruta
(1500−1000 BC) and was updated by the Buddhist scholar Nagarjuna (400-500 AD).
Bhela Samhita is attributed to Atreya Punarvasu (1500-1000 BC). Later in a long journey
other different sages and scholars did further study, investigation and experiments and
provided the booklet to follow rules, regulations and methodology (Samhita) (Mukherjee
and Wahile, 2006).
In Nepal and India there are substantial number of governmental and nongovernmental organizations providing ayurvedic knowledge and treatment, and thus have
been a major source of health care in subcontinent.
Treatment is provided by Ayurvedic physicians called the vaidya or kaviraj who
are trained in the Ayurvedic colleges and universities. The other type includes those who
learn the knowledge and skill of the profession from their father or from the gurus
(teachers). From the very childhood, they worked as an apprentice with their father or the
guru (teacher) in the guru-sishya (mentordisciple) mode and obtain the required
knowledge and skill about the healing practice (Gewali et Al., 2008).
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Health or sickness depends on the presence or absence of balanced state of the
total body matrix including the balance between its different constituents. Both the
intrinsic and extrinsic factors can cause disturbance in the natural equilibrium giving rise
to disease. This loss of equilibrium can happen by dietary indiscrimination, undesirable
habits and non-observance of rules of healthy living. Seasonal abnormalities, improper
exercise or erratic application of sense organs and incompatible actions of the body and
mind can also result in creating disturbance of the existing normal balance.
Ayurveda takes into consideration of the whole body, mind and spirit while
dealing with the maintenance of health, promotion of health and treating ailments, and
thus finds increasing acceptability in many regions of the world (Govindarajan et al.,
2005). Ayurvedic treatment also includes the opening channels which transport fluids,
and that the channels can be opened up by massage treatment using oils derived from
plant source since unhealthy channels are thought to cause disease.
The treatment consists of restoring the balance of disturbed body-mind matrix
through regulating diet, correcting life-routine and behaviour, administration of drugs. In
Ayurveda, the diagnosis of disease (illness) is done by carefully examining pulse, urine,
stool, tongue, vision, appearance by using the five senses , and is given suitable drug with
specific properties and action is prescribed in a human disease with particular symptoms
(Gewali et al., 2008).
In treatment the drug used is mostly obtained from plant parts like roots, leaves,
steam, fruits, bark, seeds or whole plant, Animal source like milk, bones, and gallstones,
minerals and metals source including sulphur, arsenic, lead, copper sulfate and gold and
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alcoholic beverages. The plants used for hepatoprotectives drugs include Eclipta alba,
Tephrosia purpurea, Zingiber officinale, Cichorium intybus, Andrographis paniculata,
Boerrhaavia diffusa, Picrorhija kurroa, and Phyllanthus amaris as mentioned by
Sharma, 2012.
1.1.5 Traditional Chinese Medicine System
While talking about the History of Chinese medicine system, we should talk about
the Traditional Chinese medicine system (TCM) and Tibet medicine.
TCM has been carried over for thousands of years for a variety of clinical
treatments associated to different kinds of diseases and symptoms in China. Clinical
diagnosis and Chinese herbology are very important components of TCM. The typical
TCM diagnostic methods are inspection, auscultation/olfaction, inquiring and palpation.
TCM is based on the holistic principles and emphasizes harmony with the universe. TCM
considers the human at the center of the universe as an antenna between celestial and
earthly elements. Water, earth, metal, wood and fire are the five elements of the material
world. The world is a single unit and its movement gives rise to yin and yang, the two
main antithetic aspects (Patwardhan et al., 2005 and Xua et al., 2009).
Traditional Chinese medical theory plays emphasis on integrated care of body,
and then removes symptoms. The basic theory of TCM describes that internal organ
systems including five zang organs (liver, kidney, heart, lung, spleen) and six fu organs
(gall bladder, stomach, small intestine, large intestine, urinary bladder and the four bodily
humors (blood, moisture and essence) play an important role in balancing the yin and
yang in human body. (Patwardhan et al., 2005; Xua et al., 2009) The zang organs reflect
8

yin; the fu organs yang. Each zang organ is inextricably woven into a complex interactive
web of coexistence and mutual restraint with a corresponding fu organ, and each pair of
organs is associated with the physical properties and natural phenomena of one of the five
elements. Proper formation, maintenance and circulation of these energies are essential
for health. When the two energies fall out of harmony, disease develops. Zang-fu organs
coexist in mutually dependent Yin-Yang relationships, the diseases and illnesses to which
they are prone can affect not just one, but two or more organs simultaneously. Under
such circumstances, it is common to witness a variety of competing syndromes.
The physician takes into account this concept while treating patients. Chinese
herbal medicine including plants, animals and minerals are used to correct this imbalance
of yin–yang in the human body (Patwardhan et al. 2005; Xua et al., 2009).
Traditional Chinese medicine has been used by Chinese people from ancient
times. Although, animal and mineral materials have been used, the primary source of
remedies is botanical. Botanical products are used only after some kind of processing,
which may include, for example, stir-frying or soaking in vinegar or wine (Li, 2000).
Li et al., 2004 compiled the review of 86 natural medicines with regards to their
origin, anti-diabetic active principles and/or pharmacological test results, which were
commonly used in the traditional Chinese medical system and had demonstrated
experimental or/and clinical anti-diabetic effectiveness. With the distinctive traditional
medical opinions and natural medicines mainly originated in herbs, the traditional
Chinese medicine performed a good clinical practice.
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There are hundreds of prescriptions to aim directly at different symptoms of
diabetes, and about 100 of natural medicines and preparations are used in these
prescriptions or folk Simple Recipes and diets for diabetes care in China, most of which
are derived from plants. The active components isolated from the roots of Pueraria
lobata (Willd.), Panax quinquefolium L., rhizome of Rehmannia glutinosa (Libosch.),
extracts of all parts of ginseng (the roots, stems, leaves and fruits) were used to cure
diabetic.
1.1.6 Unani System
Unani System of Medicine was originated in Greece and is based on Hippocrates’
Humoral theory (Akhtar J. et al., 2008). The teaching of Hippocrates forms the basis of
theoretical frame work of Unani Medicine. Subsequently, further study, practice and
modification, improvement done by Galen and then by Arab and Persian physicians,
scholars and philosophers enriched into a complete, systematic form, whereby it
flourished into a Golden Era. The bulk of Greek knowledge was translated into Arabic,
and thus became most prominent principle of medicine in Arabic country. From Middle
East to South East Asia it was transferred by Arab and Persians where it along with the
Ayurveda now becomes the most prominent alternate medicine.
Unani medicine describes that human body is composed of four fundamental
elements: earth, air, water and fire with four kinds of temperaments cold, hot, wet and
dry. The body fluids are composed of four kinds of humors: blood, phlegm, yellow bile
and black bile, and these humors have their own temperament (Ahmad, 2007). For the
propitious function of body and mind to be healthy, there should be harmonious relation
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between elements, humour and temperament, and any as such perturbation might lead to
diseases. To maintain proper health and prevent diseases everybody should be cautious
about the surrounding environment and vital factors including air, food & drinks, bodily
movement & repose, psychic movement, sleep & wakefulness, and evacuation &
retention.
To check the condition of illness or be affected by diseases careful examination of
pulse, stool and urine is carried out. The treatment is broadly categorized into Regimental
therapy involving use of exercise, climate change, massage, venesection, leaching,
cupping and diet therapy. Pharmacotherapy is another method of treatment that includes
the consumption of drugs, and these drugs include mostly the herbs along with animal
and mineral sources. The drug is given either alone or in combination. The third method
of treatment is to carry out surgery of minor degree (Akhtar et al., 2008; Ahmad, 2007).
1.1.7 Homeopathy
Homeopathy is an art of healing science that comprises two words, root being
derived from Greek, homoios means similar or like treatment and pathos means of
diseases. So the literal meaning of the word homeopathy means like treatment of disease.
Invention of Homeopathy is credited to Samuel Hahnemann (1755-1843), a German
physician. It is an alternative medical system that grasps a holistic, natural approach
where a person is treated as whole where mind, forces of body, and emotions are
assumed to be employed persistently to maintain the condition of harmony (Roberts,
2001). Any kind of disorder in harmony of mind and body with emotions causes diseases.
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The basic principles on which homeopathy depends are (i) the law of similar (ii)
the principle of the single remedy and (iii) the principle of the minimum dose. These laws
can be described as the drug (remedy) that can show symptoms of disease in a healthy
person can cure the same disease in a sick person but should be provided in extreme
dilute condition to retain therapeutic efficiency with minimum side effects. To cure
diseases only one remedy having its own peculiar character that matches with sick
person’s character should be given (Chase, 2001).
1.1.8 Folk Medicine
Folk medicine is a traditional medicine practice system that has been carried out
by humankind for a long period so as to survive from the undesirable conditions of the
nature. Using natural sources including herbs, animals and minerals, it came to their
tradition. Especially to survive from the illness conditions such as in mitigating the pain
and treating physical and mental problems, they started to use mainly natural plant source
and learned to pursue drugs in barks, seeds, fruit bodies, and other parts of the plants.
Selection of plant sources was carried out in trial and error method where they looked
upon the condition of the people after treatment. The useful herbs were taken as medicine
and its effectiveness as a drug and treatment methodology was transformed from
generation to generation orally from family member. Later, it was practiced by some
skilled people within a family and in some cases a tribal group or whole caste. The
benefits of one society were transferred on, which further upgraded the old properties,
innovating novel ones, and so on continuing to modern days (Petrovska, 2012). Since
people used the herbs near to them, it became the inherent part of their culture which
further expanded to their spiritual beliefs.
12

Folk medicine practitioners use a variety of methods to treat illnesses. Each folk
healer has specific treatments, which often include prayer, dancing, medicinal herbs,
massage, sweat baths, coining and other practices outside the realm of modern medicine.
Nearly every family has some specific home remedy that has been learned and passed
down by older family members, and even in the face of more modern health beliefs they
will continue to use these folk remedies before seeking traditional medical treatment
(Robertset al., 2002).
Affordability of these folk medicines by the local people is certainly
advantageous, and the majority of people in the rural area of world are out of the reach of
expensive modern treatment. For such people, folk medicines are the answer.
Furthermore, by doing so, they are supporting the livelihood of their healers to some
extent. Herbalists believe that these folk medicines have been time tested, and therefore
they have no or little side effects. This adds to the beauty of folk medicines. It is
generally believed that around seventy-five to eighty percent of world population
depends upon one or the other form of traditional medicine for primary health care. In
many developing societies, thus, this form of the traditional medicine is kicking and
alive. Perhaps, this further fortifies the standardization of these practices through careful
research and development (Gewali et al., 2008).
1.1.9 Plants and Medicine
Utilization of plant materials as medicine since thousands of years (Samuelsson,
2004). The isolation of morphine from Papaver somniferum started new era of obtaining
phytochemicals from plant materials (Balanus et al., 2005). Since then a large number of
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active phytochemicals have been extracted, and have shown to be efficacious in curing a
number of illness including cold, cough, digestive problems, diarrhea, fevers, asthma,
swellings, cuts and wounds, pain, weakness, burns, impotence, vomiting, diabetes, cancer
etc. They have also been implicated as antioxidants, antidepressant, antiasthmatic, antiaging, antifungal, antibacterial etc. There are myriad of evidences herbal remedies
prepared from leaves, bark, roots, seeds juice, stem, whole plant, in dry powder, paste,
liquid and other forms(Balick and Cox, 1997; Samuelsson, 2004) by extracting the
chemical constituents dissolving and boiling with solvents like water, alcohol, acetone,
DCM and have been used since long time. To show the pertinence of traditional system
an ethnopharmacological methodology has been applied to identify potential new drugs
from plant sources by using modern techniques of spectroscopy and chromatographic
technique. The phytochemical study has shown that these plants contain valuable
chemical compounds including alkaloids, flavonoids, terpenoids, saponoins, amino acids,
glucose content, and other essential components. Some of important active components
subsume podophyllotoxin, topoisomerase II inhibitor extracted from American
Mayapple, Podophyllum peltatum and Podophyllum emodii Wallich from Indian
subcontinent(Imbert, 1998; Srivastava et al., 2005), camptothecin, topoisomerase I
inhibitor isolated from Chinese ornamental tree, Camptoteca acuminata Decne
(Nyssaceae) in 1966 (Wall et al., 1996), antineoplastic agents vincistrine and vinblastine
from Catharanthus roseus G. Don. (Gueritte et al., 2005), Paclitaxel isolated from the
bark of the Pacific yew Taxus brevifolia Nutt. has exhibited potential activity in breast
cancer treatment (Om Prakash et al., 2013), a sesquiterpene lactone artemisinin isolated
from Artemesia annua have been well implicated in traditional medicine as antimalarial
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drugs (van Agtmael et al., 1999). Moreover, another antimalarial drug, quinine isolated
from the bark of Cinchona succrirubra (Bruce-Chwatt, 1988), galantamine isolated from
Galanthus woronowii Losinsk to treat Alzheimer’s disease (Heinrich and Teoh, 2004),
calanolide A isolated from Calophyllum lanigerum, a tropical rainforest tree as a
potential anti-HIV drug (Kashman et al., 1992).
There are numerous herbal remedies used as a household medicine and culinary
herb, implicated in Ayurveda and TCM for a long period of time. Curcuminoids isolated
from rhizomes of Curcuma longa L., commonly known as turmeric, displays antioxidant
and anti-inflammatory, anti-tumor, antifungal activities (Apisariyakul et al., 1995; Xia et
al., 2007). Rhizomes of herb Acorus calamus and Acorus gramineusis have been used in
Ayurveda, TCM, and Traditional Korean medicine to cure neurosis, epilepsy, loss of
memory, hysteria, gastrointestinal disorders such as colic pain and diarrhea, antifungal
activity due to presence of β-asarone (Gilani, 2006; McGaw et al., 2002). Alcoholic
extracts have been demonstrated as the substantial improvement of memory and
cognition in old age (Oh et al., 2004).The fruits and seeds of genus Xanthoxylum
including species armatum and nitidum contains active phytoconstituents, Coumarins and
alkaloids such as bergarpten, umbelliferone, skimmianine and schinifolin act as
anthelmintic, stomachic, carminative, deodorant, disinfectant and antiseptic including
fever, dyspepsia and the expelling of roundworms (Waheede et al., 2011; Singh et al.,
2011; Negi et al., 2011). Figure 1.1 below shows some phytochemicals that have been
used as traditional medicines.
There are several other plants used, whose detail phytochemical study and limited
clinical trials have been carried out that underscores their efficacy as medicine since they
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are directly procured from nature with minimal side effects alongside its cheap and easy
usage. Yet, to meet the standard created by modern medicine system, it needs further
investigation.

Morphine

Quininine

Atropine

Artemisinin

Digoxin

Fig 1.1 Traditionally Used Medicines from Plants
1.2 Cancer
The chloroform crude bark extract and also the phytochemical isolated from plant
species Drypetes lasiogyna have been shown to possess excellent cytotoxic activities
against cancer cell lines 5637, MCF-7 and MDA-MB-231. So, research is focused on in
vitro and in silico study against cancer.
Cancer denotes to a diseases or symptoms characterized by an unusual, and
uncontrolled proliferation of cells, leading to disruption of cell mechanism via genetic or
epigenetic alterations, giving rise to neoplastic growths or tumor formation of cells. Thus,
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cells are more invasive, and could destroy the surrounding healthy tissue, thereby
spreading throughout the body leading to metastasis (Hanahan et al., 2000; Gupta et al.,
2006).
Cancer is one of the most severe health problems in both developing and
developed countries, worldwide. Cancer is a key health issue across the world, causing
substantial patient morbidity and mortality. It is one of the most leading causes of death
all across the world. Over half of the cases occurred in the developing world (Xia et al.,
2014).More than 70% of all cancer deaths occurred in low- and middle-income countries.
(Cancer Research UK, 2011). Moreover, cancer is the second leading cause of death
among children among the ages from one to fourteen, and has further been responsible
for 25% of all deaths today (Jemal et al., 2005). Seventy-seven percent of all the cancers
diagnosed are observed in people aged 55 years or older (ACS, 2002). There were 10.9
million new cancer cases diagnosed in USA and 6.7 million deaths in 2002 (Tan et al.,
2002). These figures indicate that the death toll from cancer is going to rise with the
aging of US population.
In 2008, approximately 12.7 million cancer cases were diagnosed (excluding nonmelanoma skin cancers and other non-invasive cancers) and 7.6 million people died
(Cancer Research UK, 2011) and in 2010 nearly 7.98 million people died (Jemal et al.,
2011) across the world. Deaths due to cancer are projected to continuously increase and it
has been estimated that there will be 11.5 million deaths in the year 2030 (Cancer
Research UK, 2011).27 million new cancer cases and 17.5 million cancer deaths are
projected to occur in the world by 2050 (ACS, 2007).
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Among the most common (lung, stomach, colorectal, liver, breast) types, cancer
accounted for two-fifths of the total cases of cancers diagnosed worldwide. Lung cancer
has continued to be the most common cancer diagnosed in men, whereas breast cancer is
the most common cancer diagnosed in women (Cancer Research UK, 2011).
Cancers as a whole is accountable for approximately 13% of all deaths each year
with the most common being: lung cancer (1.4 million deaths), stomach cancer (740,000
deaths), liver cancer (700,000 deaths), colorectal cancer (610,000 deaths), and breast
cancer (460,000 deaths) (Chou et al. 2011). This makes cancer as one of the invasive
disease. Over half of the cases occur in the developing world (Xia et al., 2014).Cancer is
a dreadful disease which brings tremendous social distress, psychological suffering and
hardship to the patients and relatives (Abdulbari Bener et al., 2007). Hence, there is an
exigent need to address this brutal form of disease.
1.2.1 Factors Causing Cancer
It is now established that cancer is principally caused by environmental risk and
changing lifestyle factors including consumption of tobacco, smoking and alcohol,
obesity, physical inactivity, chronic infection and exposure in the workplace to radiations
(Parkin, 2004; WHO, 2010). For young adults and adolescents, genetic predisposition
along with exposure to risk factors is main cause of cancer (Bener et al., 2007).
1.2.2 Types of Cancer
Usually most of the cancers are named on the basis of cell or organ where it
affects which accounts for more than 100 different types; each type has its own
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characteristics symptoms, causes and approaches of treatment (NCI, 2015). These types
include:
 Carcinoma- Most common type of cancer composed of epithelial cells (Lemoine
et al., 2001). Depending on type of epithelial cell where Carcinoma begins.
a) Adenocarcinoma - Epithelial cells include glandular tissues that secrete
fluids or mucus. Most cancers of the breast, colon, and prostate are adenocarcinomas.
b) Basal cell carcinoma (BCC) - BCC is the most common type of skin
cancer that arises in the skin’s basal cells due to long term exposure to sunlight.
c) Squamous cell carcinoma (SCC) - SCC is the second most common type
of skin cancer that originates in squamous cells, probably due to the prolonged
exposure to sunlight containing UV rays , which commonly affects the body parts
including mouth, lips, head, neck, arms, legs, hands, genitals.
d) Transitional cell carcinoma (TCC) - TCC arises from the transitional
epithelium and characteristically occurs in the urinary system: the kidney, urinary
bladder, and accessory organs.
 Sarcoma- Sarcoma grows in in the connective tissue of the body including bone
and soft tissue such as fat, cartiledge, blood vessels, muscle, nerves. Soft tissue
sarcomas are more common than bone sarcomas (NCI- 2014).
 Leukemia- Leukemia originates in bone marrow with the excessive and
uncontrolled proliferation in the number of white blood cells which may not
function well. This leukemia cell suppresses the development of normal blood
cells, which may arise due to smoking, exposure to radiation and improper use of
carcinogenic solvents like benzene. In some cases, it is genetically transferred
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which may have been inherited from the family are the ones at highest risk.
Usually leukemia is prevalent in adults older than 55 years and in children
younger than 15 years (NCI, 2014).
 Lymphoma- Lymphoma develops when lymphocytes abnormally grow
especially in lymph nodes and lymphatic system. Mainly, two types of lymphoma
non-Hodgkin's

and

Hodgkin's

along

with

multiple

myeloma

and

immunoproliferative diseases have been categorized. About 90% case covered by

non-Hodgkin's type lymphoma are formed from the perturbation of B cells control
mechanism (WHO, 2014).
 Melanoma- In melanoma malignant cells cultivates in melanocytes, usually in
the skin. The risk factors include exposure to UV rays of sunlight, unusual moles
and health history (WHO, 2014 and NCI, 2015).
There are other types of tumors for e.g. - Germ cell tumor, Blastoma, Brain and
Spinal Cord Tumors, Neuroendocrine Tumors, Carcinoid Tumors.
1.2.3 Treatment of Cancer
The current method of treatment of cancer involves different techniques including
surgery, chemotherapy, radiation therapy, immunotherapy, gene therapy, alternative
therapy etc. Our main concern is on chemotherapy since it efficiently uses chemical
compounds as a medicine or drug for treatment where a single or combination of drugs
(chemotherapeutic agents) is used as part of a standardized chemotherapy regimen.

Chemotherapy works by stopping or inhibiting the abnormal and rapid growth
of cancer cells. It can be used as an adjuvant treatment usually after other therapy method
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such as surgery or radiation is employed or as palliative treatment to minimize the
discomfort caused by cancer or slows the progression of disease to prolong the patient's
life. The purpose of adjuvant chemotherapy is to reduce the risk of recurrence or to
prolong survival. As a primary treatment, chemotherapy is used for some cancers such
as Hodgkin's disease, leukemia, Burkitt's lymphoma, localized diffuse large cell
lymphoma, Wilms' tumor, small cell lung cancer, and testicular cancer (NCI, 2016).

The chemotherapeutic drugs used in cancer treatment includes alkylating agents,
taxanes, Topoisomerase

II inhibitors, anthracyclines,

antimetabolites, platinum

complexes, tubulin interactive agents, plant alkaloids such as Vinca alkaloids etc.

Alkylating agents were one of the earliest classes of drugs used to treat cancer,
beginning in the 1940’s. The cytotoxic effects are directly related to the alkylation of
DNA, where alkylating agents gets covalently attached to the base guanine of DNA at 7th
position by an alkyl group, thus preventing the proteins from linking up as they should,
thereby causing the breakage of DNA strands and, eventually, the death of the cancer
cell. However, being cytotoxic can damage the surrounding healthy cells also and they
possess carcinogenic and mutagenic characteristics also. Treatment with these drugs
carries with it the risk of secondary cancers, such as leukemia (Walsh, 2009). These
drugs are nonspecific i.e., can work in all phases of cycles specially of important in slow
developing cancer for a wide range of cancers such as leukemia, Hodgkin disease, nonHodgkin's lymphoma, sarcoma, multiple myeloma and as palliative chemotherapy in lung
and breast and ovarian cancers. The dose of drugs is usually given by intravenous
injection or orally in the form of tablet. These drugs either follow SN1 or SN2 mechanism
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for their action. There are a number of these drugs that have been tested clinically but
most commonly used, which are here below:
a)

Nitrogen

mustards:

mechlorethamine

(Mustargen®),

melphalan,

cyclophosphamide (Cytoxan®), chlorambucil (Leukeran®) and ifosfamide (Ifex®).
b) Alkyl sulfonates: busulfan
c) Nitrosoureas: streptozocin (Zanosar®), lomustine and carmustine (BCNU®),
d) Ethylenimines: thiotepa
e) Triazines: temozolomide (Temodar®) and dacarbazine (DTIC)
Chlorambucil is used often for the treatment of chronic lymphocytic leukemia,
ovarian carcinoma, and lymphoma, but has been used less often in high-dose combination
therapies than the other nitrogen mustards that are described here. This agent is well
tolerated by most patients and can be used in patients who have severe nausea and
vomiting with cyclophosphamide or melphalan. Cyclophosphamide produces less
gastrointestinal and hematopoietic toxicity than other alkylating agents. It works for a
wide range of cancers. Ifosfamide is a structural isomer of cyclophosphamide that has
been especially implicated in the treatment of testicular tumors and sarcomas (Antman et
al., 1990). Also, melphalan is an alkylating agent that is used in the treatment of multiple
myeloma, ovarian cancer, and breast cancer. Melphalan is an amino acid analog that
enters cells and crosses the blood–brain barrier through active transport systems (Russo et
al., 1989; Fisher et al., 1990).
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The cytotoxic effectiveness of bifunctional alkylating agent is greater than
monofunctional agents due to the availability of two alkylating groups, however further
increase in alkylating group has no effect. The interstrand cross-linking of DNA was
responsible for the cytotoxic activity of the bifunctional alkylating agents. There is a
good correlation between cytotoxicity and the formation of interstrand cross-links by
bifunctional alkylating agents showing the good association between them.
Anthracycline antibiotic drugs such as doxorubicin, daunorubicin are frequently
used in leukemia and breast cancer therapy. They have been also used in lymphomas,
stomach, uterine, ovarian, bladder cancer, and treatment. The derivatives and analogs of
second generation shows efficacy in cytotoxic activity (Minotti et al., 2004), however
higher risk of cardiovascular complications is still predominant (Volkova1 et al., 2011).
The mechanism of action is believed due to the intercalation of drugs into the base pairs
in DNA minor grooves and free radical action to the ribose in the DNA.
Taxanes based regimens are cytotoxic diterpenes compounds found to be most
effective for the treatment of metastatic and node- positive breast cancer as
monochemotherapy or in the adjuvant setting used either in combination usually with
anthracyclines and alkylating agents or sequential therapy. Taxanes were introduced in
mid-1990s and since then a larger number of tests, and clinical trials have been carried
out which showed its efficacy. Along with MBC, taxanes have been also used for the
treatment of non- small cell lung cancer, prostate, ovarian, melanoma, hepatocellular
carcinoma, gastric and Pancreatic Cancer. Mostly used taxanes include Paclitaxel initially
extracted from natural source Pacific yew trees Taxus brevifolia, a more effective
semisynthetic derivative of Paclitaxel is Docetaxel (Taxotere) obtained from extracts of
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the needles of the European yew tree Taxus baccata and more effective semisynthetic
derivative of paclitaxel, derived from extracts from the needles of the European yew tree
(Taxus baccata), Cremophor EL (CrEL-) paclitaxel (Taxol®) and nab-paclitaxel
(Abraxane). The mechanism involved in the action is thought to be the binding of taxanes
to the microtubules that obstruct the microtubule dynamics and results in cell cycle arrest
in G2 and M phase, leading to apoptosis. The side effects related to taxanes include
Hematopoietic and neurologic toxicities whereas alopecia, vomiting, Nausea, stomatitis,
diarrhea, metallic or bitter taste sensation and liver function test abnormalities that occur
as mild effect (Nabholtz et al., 2005; Debra, 2006; Fauzee et al., 2011; Gradishar, 2012).
Vinca alkaloids are cell-cycle specific anti-tubulin cytotoxic drugs, generally used
in combination therapy regimens. The inhibitory activity may be due to binding of these
drugs with tubulin and interrupting microtubule dynamics of mitotic spindle, thus
arresting the cells at M phase leading to apoptosis. It includes alkaloids originally
extracted from plants such as vincristine and vinblastine to semisynthetic derivatives such
as vindesine and vinorelbine(VRL) (Ngan et al., 2001; Kufe et al., 2003) and synthetic
Vinflunine(Schutz et al., 2011), and has been widely used for the treatment of both
leukemias and solid tumours. In combination with other drugs vincristine (VCR) is used
in against hematological and lymphatic neoplasms, treatment whereas vinblastine is used
against choriocarcinoma and embryonal carcinoma of the testes and in breast cancer.
Vindesine is used in non-small cell lung cancer. The major side effect of VCR includes
neuropathy and VLB causes bone marrow suppression. Improved efficacy and lower
toxicity is demonstrated by semisynthetic VRL, which is used usually in treatment of
metastatic

breast cancer, ovarian cancer, non–small-cell lung cancer and also used in
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prostatic carcinoma, lymphoma and esophageal cancer. Vinflunine is used to cure
bladder, non-small cell lung and breast cancers. The main side effects include myelo
suppression and constipation (Ngan et al., 2001; Nobili et al., 2009).
1.2.4 Plants in Cancer Treatment
The anticancer drugs and numerous chemotherapeutic methods demonstrated
increasing mortality rate with severe side effects that the drugs applied usually in
combination harms normal cells also. So the research is focused on developing novel
drugs with improved efficacy with lesser side effects. The screening of plant extracts for
antitumor agents inspired by the discovery and development of the Vinca alkaloids was
initiated by NCI (USA) during 1950s that spanned a period of around 30 years, screening
around 35,000 plant samples focused mainly in temperate regions but new screening
technology led to the revival of collections of plants and other organisms in 1986 from
tropical and sub-tropical regions of the world (Cragg et al., 2005; Ghantous et al., 2010).
The achievement of screening program is the discovery of novel chemotypes drugs
displaying a range of cytotoxic activities including taxanes and camptothecins (Cassady
and Douros, 1980). Natural products and their derivatives accounts for around 67% of
anticancer drugs that are available today (Balunas et al., 2005).Based on chemical
structure molecule may be alkaloid, flavonoid, terpenoids, quinones, saponins, steroids,
polysaccharides, and glycosides (Xia et al., 2014). Potential anticancer activity of a large
number of phytochemicals has been screened and examined by both in vitro and in vivo
methods. Below, figure 1.2 represents some classes of anticancer phytochemicals that has
been mostly used.
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The naturally occurring lignin podophyllotoxin was extracted from genus
Podophyllum that includes American Mayapple Podophyllum peltatum and Podophyllum
emodii Wallich from Indian subcontinent, which was used as purgative to cure warts,
however its cytotoxic activity was shown only in 1974 where it was found to have
strongly binded to tubulin irreversibly. The class includes podophyllotoxin,
deoxypodophyilotoxin, peltatins and its modified analogs etoposide and teniposide which
arrest cell growth by inhibition of topoisomerase II (Imbert, 1998 and Srivastava et al.,
2005). The semisynthetic analogs etoposide and teniposide are more prominent than
podophyllotoxin where these analogs showed cytotoxic activity against different tumors
comprising lymphoma, leukemia, testicular and small-cell lung cancers (Cragg et al.,
2005 perspective paper).
Alkaloids are heterocyclic compound containing nitrogen atom in the ring which
have been extracted from plants. A number of alkaloids have proven to be effective in
cancer treatment. Vinca alkaloids such as vinblastine and vincistrine isolated from
Madagascar periwinkle, Catharanthus roseus G. Don. (Apocynaceae) also known as
Vinca rosea possess antitumor activity (Gueritte et al., 2005).
Pentacyclic alkaloid camptothecin isolated from Chinese ornamental tree,
Camptoteca acuminata Decne (Nyssaceae) in 1966 (Wall et al., 1996) acquires improved
cytotoxicity and inhibition of topoisomerase I in comparison to the water-soluble analogs
due to lipophilic character (Huang et al., 2007; Lu et al., 2012). Campothecin and 9methoxycamptothecin have also been isolated from Nothapodytes foetida (Fulzele et al.,
2001). So the research was focused on to synthesize camptothecin derivatives such as
topotecan and irinotecan etc. Topotecan is used for the treatment of ovarian and small
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cell lung cancers, while Irinotecan is used for the treatment of colorectal cancers (Rahier
et al., 2005 and Demain et al., 2011).
Berberine isolated from roots of Coptis chinensis Franch shows anticancer
activities over HCT116 (human colon cancer cell line) and A549 (human lung
adenocarcinoma cell line) (Li et al., 2014 and Zheng et al., 2014).
Combretastatin and its related compounds combretastatins A1, combretastatins
A2 isolated from South African plant Combretum caffrum are tubulin inhibitors and have
shown potent activity against anaplastic thyroid cancer in Phase II clinical trial (Pinney et
al., 2005; Cragg et al., 2005).
Taxanes including Paclitaxel also known as taxol isolated from the bark of the
Pacific yew Taxus brevifolia Nutt. (Taxaceae) and its semisynthethetic derivative
docetaxel (Taxotere) have been used in the treatment of cancers such as breast, ovarian,
non-small-cell lung cancer and also in Kaposi sarcoma, psoriasis, multiple sclerosis, and
rheumatoid arthritis. A number of taxane derived drugs are in clinical or preclinical
development (Om Prakash et al., 2013).
Colchicine extracted from Colchicum autumnale and Gloriosa superba L. and its
derivatives namely, 3-demethyl colchicine, colchicoside, thiocolchicocide showed
improved activity against certain leukemic cells and solid tumors where they act as potent
anti-mitotic drug both in vitro and in vivo (Dubey et al., 2008).
Other important anti-cancer agents include homoharringtonine obtained from
Chinese tree, Cephalotaxus harringtonia var. drupacea (Sieb and Zucc.) and elliptinium
isolated from species of Apocynaceae family, including Bleekeria vitensis A.C. Sm.,
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possesses cytotoxicity against a range of different cancer cell lines (Itokawa et al., 2005;
Cragg et al., 2005).

Podophyllotoxin

Camptothecin

Vinblastine

Vincistrine

Taxol

Etopside

Fig 1.2 Anti-Cancer Medicines Obtained from Plants
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1.3 Plant Collection Site
Plant material Drypetes lasiogyna was collected from Paluma rain forest,
Northern Queensland, Australia and Tabebuia bahamensis from Abaco Island, Bahamas.
1.3.1 Paluma Rain Forest, Northern Queensland, Australia
The plant material used for the study was collected from Paluma rain forest (Mt.
Spec State Forest) that lies on the Northern Queensland, Australia. The area is located
18°57’ S, 146°11’ Elevation 900 m; 84 km north of Townsville (Setzer et al., 2001). The
nice location of Paluma rain forest is shown in figure 1.3 below.
Approximately, 74% of Paluma Range National Park is within the Wet Tropics
World Heritage Area (WTWHA) which extends for about 450 km between Cooktown
and Townsville. These criteria recognize the area's exceptional natural beauty and the
importance of its biological diversity and evolutionary history, including habitats for
numerous threatened species. The WTWHA also has cultural significance for Aboriginal
people who have traditional links with the area and its surroundings.
The rain forest provides residency for a variety of flora and fauna including
distinctive red flowers of weeping bottlebrush trees Callistemon viminalis, Eucalyptus
woodland with ironbarks Uromys caudimaculatus, bloodwoods Corymbia clarksoniana,
Corymbia intermedia, Moreton Bay ash Corymbia tessellaris and poplar gums
Eucalyptus platyphylla, cocky apple Planchonia careya, hoop pines Araucaria
cunninghamii , riverine vegetation with casuarinas Allocasuarina torulosa and
melaleucas Melaleuca dealbata (Queensland Government, 2013).
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Fig 1.3 Paluma Rainforest, Northern Queensland, Australia
1.3.2 Abaco Island, Bahamas
Abaco, Bahamas is a group of islands and cays (as shown in figure 1.4) along
with shallow banks and rocks (Albury, 1975) in the northwest portion of the Bahamas
located just North of the Tropic Zone, 26° North and 77° West, around 180 miles east of
south Florida forming a 120 mile long chain stretching over 650 square miles. It
comprises of 29 islands with Great Abaco and Little Abaco Island being main islands,
along with smaller barrier cays such as green turtle cay, treasure cay, great guana cay,
elbow cay, walker’s cay, Spanish cay with Marsh Harbour being a commercial hub. On
the east side, Abaco island is bordered by Atlantic Ocean, on the west by shallow waters
of the Little Bahama Bank, and N.W. Providence Channel and N.E. Providence Channels
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(Walker et al., 2008) on the south. The tradition of practicing of bush medicine to
Bahamas was originally carried by African slaves, and in fact, is still in practice. Nearly
100 plants such as Aloe vera (aloe plant), Solanum verbascifolium (slave bush),
Artocarpus altilis (breadfruit), Tabebuia bahamensis (five fingers), Cuscuta (love vine),
Carica papaya (green papaya), Salvia serotina (catnip) have been used in medicinal
treatment of common ailments such as indigestion, colds, diarrhea, and headaches
(Gibson, 2015 and Hanna-Smith, 2005).

Fig 1.4 Abaco Island, Bahamas
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1.4 Drypetes lasiogyna
The genus of Drypetes plants are extensively used in African folk medicine to
treat various diseases such as bronchitis, ailments of the digestive tract, fever, kidney pain
and rheumatism (Ata et al., 2011). The plants of these genus have been suggested to
possess anti-inflammatory and analgesic activity (Wandji et al., 2000; Chungag et al.,
2001), and are found to be actively involved as CNS depressants too (Sudharshan et al.,
2009). It is worth noting that the species was different, although this genus has been used
to treat similar disorders. Earlier phytochemical studies on some Drypetes plant species
including D. parrifolia, D. laciniata, D. inaequalis, D. armoracia, D. gossweileri, D.
molunduana, D. roxburghiihave suggested to yield flavonoids, chalcone glycosides,
saponins, tripterpenoids, phenolics, alkaloids, etc. (Nenkep et al., 2008; Fannang et al.,
2011; Awanchiri et al., 2009; Wandji et al., 2003; Wandji et al., 2000).
Drypetes lasiogyna (whole plant along with trunk as shown in figure 1.5) is a
species of Drypetes belonging to the family Putranjivaceae, which was formerly kept in
family Euphorbiaceae. It is also known as Drypetes deplanchei, and is commonly known
as yellow tulip, grey bark etc. The plant grows to be 25 meters stem width of 60 cm,
leaves with elliptical, ovate to ovate-oblong in shape and fruits are bright red drupe.
While talking about the distribution and ecology of lasiogyna species, it occurs in WA,
NT, CYP, NEQ and in south up to New South Wales in altitude ranging from near sea
level to 750 m. It also occurs in New Guinea and New Caledonia growing in monsoon
forest and the drier types of rain forest. Several species of Drypetes have been reported to
use as a traditional medicine, and have been well tested for their biological activity. A
comprehensive study on D. lasiogyna extracts including chloroform and ethanol leaf and
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bark extracts have been carried out that includes antimicrobial, antiviral, cytotoxic
screening and brine shrimp lethality, thereby, providing valuable information (Setzer et
al., 2001).
The genus term Drypetes term was given by Vahl, 1807, that comprises
approximately 200 species kept in Euphorbiaceae family by Webster, 1994, and later was
kept separately in Putranjivaceae family. Most species of this genus are dioecious trees
or shrubs, widely distributed in tropics, subtropics and neotropics rainforest region. The
genus Drypetes are reported to contain more than 200 species found in Australia, Africa,
southern Asia, Latin America and various oceanic islands (Forster, 1997). Moreover,
around 17 species of Drypetes have been found in Americas, mostly in West Indies,
however, fewer studies have been carried out on Amazonian species (Levin, 2013).
Most of the Drypetes species are widely used in African traditional medicine for
the treatment of infectious diseases, gonorrhoea, dysentery, toothache, boils, sinusitis,
and swelling (Dalziel, 1937; Irvine, 1961).Their applications in bronchitis, rheumatism,
fever, kidney pain, and ailments of the digestive tract have also been documented in the
literature (Ata et al., 2011). Along with phytochemical studies, biological activities have
also been carried out only in fewer species including D. roxburghii, D. gossweileri, D.
molunduana, D.armoracia, D. chevalieri, D. inaequalis, D. paxii, D. sepiaria, D.
tessmanniana, D. parrifolia, D. laciniata, D. perreticulata etc., where these species have
shown to possess potent biological activities owing to the active presence of
phytochemicals such as phenolic, alkaloids, terpenoids, flavonoids, chalcone, glycosides,
saponins.
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D. gossweileri is used in helminthic diseases and rheumatism (Walker and
Sillians, 1961), whereas in Congo, the root parts have been generally implicated in the
cure of wounds and toothache (Troupin, 1983). Furthermore, the crude stem bark extracts
of D. gossweileri have been shown to have antimicrobial activity including antibacterial,
antifungal (Dupont et al., 1997; Ijah and Oyebanji, 2003; Ngouana et al., 2011),
antioxidant, antiradical (Agnaniet et al., 2003), phytotoxic activity against Lemna minor
L. (Schmelzer and Gurib-Fakim, 2008), and also have been demonstrated to contain
antiacetylcholinesterase activity and anti-α-glucosidase inhibitory activity too (Ata et al.,
2011).
Likewise, Wandji et al., 2000 carried out the phytochemical studies on aqueous
stem extract of D. molunduana Pax and Hoffm, from Cameroon, and have reported to
contain sesquiterpene lactone drypemolundein A and friedelane-type triterpene
drypemolundein B along with other known compounds. However, extract as a whole, and
sesquiterpene lactone drypemolundein A were found to exhibit strong anti-inflammatory
and analgesic. Similarly, Wandji et al., 2003 isolated two new phenolic compounds,
drypearmoracein A and drypearmoracein B along with other known compounds from
methanol extract of the dried stem bark of Drypetes armoracia Pax & Hoffm, found in
Cameroon. Besides, Furanoeudesm-1-on- 13-oic acid isolated from1:1(CH2Cl2/CH3OH)
dried stem extract of Drypetes chevalieri Beille from Kumba locality, SouthWest of
Cameroon, have also been shown to possess a potential antileishmanial activity (Wansi et
al., 2007).
Furthering, it is of great interest to the scientific community, to delve in other
species of Drypetes comprising of antimicrobial activity test against some Gram-positive
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and Gram-negative bacteria of triterpenes, obtained from extracts of whole stems and the
ripe fruit of D. inaequalis Hutch (Awanchiri et al., 2009). Correspondingly, methanol
extract of the whole stems of Drypetes paxii (Chiozem et al., 2009) obtained from Centre
and East provinces of Cameroon have shown to possess modest activity. Likewise,
terpenoids isolated from methanol stem bark extract of another east Cameroon sps., D.
tessmanniana, have been suggested to exhibit potential antimicrobial activity, and could
be employed in preparing new antimicrobial drugs (Kuete et al., 2010).
Furthermore, Drypetes sepiaria, widely distributed in Sri Lanka and few places of
Tamil Nadu, India have been well implicated by tribal people as folk medicine using
decoction of leaves and seeds during inflammation and pain. The paste prepared from
root is used as an antidote for scorpion bite (Arinathan et al., 2007; Bharath kumar and
Suryanarayana, 2011), and similarly, in vitro antioxidant, anti-inflammatory and
cytotoxic activities of different extracts of leaves in same species have also been recently
investigated by Gadamsetty et al., 2013.
Chinese timber plant indigenous sp. D. perreticulata Gagnep., also planted in
Vietnam and Thailand (Li, 1994) has been reported to show reasonable antioxidant and
antimicrobial activities (Chen et al., 2012). Correspondingly, new pimarane-type
dinorditerpenoids, dryperreins C and dryperreins D isolated from twigs and leaves of D.
perreticulata have shown quite a strong in vitro cytotoxicity against HL-60 human tumor
cell line (Ge et al., 2014). The phytochemical studies on another indigenous Chinese
plant D. hainanensisis have also shown new phenylpropanoids, named drypetesins A–C,
exhibiting compelling in vitro cytotoxic activities against HepG2, MCF-7, and A-549
human cancer cell line with IC50value range 5.6–14.8µM (Zhang et al., 2015).
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Fig 1.5 Drypetes lasiogyna a) Whole Plant b) Trunk
1.5 Tabebuia bahamensis
The plant Tabebuia bahamensis (as shown picture of whole plant along with trunk
in fig 1.6), commonly known as five fingers, belonging to the family Bignoniaceae is a
small tree from Bahamas found in Cuba and South Florida too. Flowering and fruiting
occurs throughout the year with the flower color ranging from white to pink, along with
leaves having 3 to 5 leaflets possessing green color on top surface and whitish on below
surface (Popenoe, 1980). The genus Tabebuia comprises of about 100 species, mostly
found in tropical and subtropical region of North America (Rahmatullah et al., 2010),
with the long documented history of traditional usage for the treatment of gonorrhea,
syphilis, fever, cold, malaria, cutaneous infections, and stomach disorders (Cragg et al.,
2005; Adonizio et al., 2006). Besides, the tea prepared from leaves of T. bahamensis are
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also considered to mitigate bodily strain and backache (Higgs, 1969), as a sex stimulant
and aphrodisiac (Halberstein, 2005), including its implications as an important
component of love potion prepared in Andros Island of Bahamas (Eshbaugh, 2014).
The plant Tabebuia impetiginosa, syn. Tabebuia avellanedae also known as
known as “ipe” (Pau d'arco), an indigenous Amazonian rainforest tree, has been used
traditionally in South American country since long time back where decoction of inner
bark of the tree have been well implicated against antimicrobial infection, fever, malaria,
syphilis, trypanosomiasis and stomach and bladder disorders, and similarly as an antiinflammatory agent (Castellanos et al., 2009 and Zhang et al., 2016). Correspondingly,
the crude drug “tayi pyta”, prepared from Tabebuia heptaphylla has been implemented in
curing wounds, syphilis, inflammations, and cancer in Paraquay (Gentry, 1992, SchmedaHirschmann et al., 2003) too.
In addition, other species used as phytomedicine includes T. aurea, also known as
Paratudo, have been reported to be used as an infusion or maceration with alcohol in
treatment of snakebite, and also as an anti-inflammatory agent (Gentry, 1992; Reis et al.
2014), whereas T. rosea and T. ochracea have been suggested to acquire antimalarial
properties (Gentry, 1992). Further, extract of T. rosea (Bertol.), have also shown to
exhibit antimicrobial, anti-inflammatory, diuretic and laxative properties, and thus, is a
source of Thai traditional medicine (Sichaem et al., 2012).
Clinical efficacy, as a potent anti-cancer and anti-leishmaniasis drug candidate, of
some species of Tabebuia is probably due to the presence of naphthaquinones,
particularly lapachol and lapachone. Likewise, the sps. Tabebuia impetiginosa, Tabebuia
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aurea, Tabebuia ochracea, Tabebuia rosea (Bertol.), and Tabebuia serratifolia (Vahl)
have been reported to acquire in vivo anti-tumor activity (Rao et al., 1968). However,
clinical trials by NCI in 1970, reported lapachol and lapachone as an effective
chemotherapeutic agent at high concentrations showing extremely toxic side-effects
(Suffness & Douros, 1980; Gentry, 1992 and Castellanos et al., 2009). Moreover, the
plants used as anti-leishmaniasis candidates include T. umbellate for cutaneous
leishmaniasis (L. braziliensis) in Bahia, Brazil, T. serratifolia bark, in Peru. The
antileshmanial activity may be attributed to the presence of naphthaquinones that have
also been extracted from T. avellanedae and T. serratifolia (Monzote et al., 2014).
The acetone bark extract of T. bahamensis (Northr.) was screened for
antileshmanial activity by Monzote et al., 2014 where it was found to be active against L.
amazonensis showing IC50 value of 17.4±3.5 μg/mL for promastigotes and 23.8±5.7
μg/mL for amastigotes, however, the cytotoxic screening for human tumor cell lines SKMel-38 and Hep-G2, MDA-MB-231 and 5637 were shown to be inactive. On the other
hand, cytotoxic screening of crude leaf DCM extract on human tumor cell lines carried
out by Shrestha et al., 2015, shown notably toxic to 5637 cells (93.0 ± 6.9% kill at 100
μg/mL), whereas it was marginally found to be toxic to MDA-MB-231 cells (58.8 ± 7.3%
kill at 100 μg/mL), and nontoxic to SK-Mel-38 and Hep-G2 cell lines. However, the
antimicrobial screening carried out by Monzote et al., 2014; Setzer et al., 2015and
Shrestha et al., 2015 on crude bark and leaf extracts did not find any significant result.
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Fig 1.6 Tabebuia bahamensis a) Whole Plant b) Stem
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CHAPTER 2
EXPERIMENTAL
2.1 Plant Collection
The plant material T. bahamensis for the study was collected by W. N. Setzer and
group in December, 2000 on Abaco Island, Bahamas. Identification had been carried out
by same group using proper field guides, and Voucher specimens were deposited on
University of Alabama in Huntsville Herbarium. The location site is 26°31.09' N, 77°
4.26' W, 13.4 m asl (12-16-2000) with code WNS2000TABA (Setzer et al., 2015). The
plant material D. lasiogyna was collected by W. N. Setzer and group from Paluma rain
forest (Mt.Spec State Forest) that lies on the Northern Queensland, Australia. The area is
located 18°57’ S, 146°11’ E; elevation 900 m; 84 km north of Townsville under permit
issued to Dr. Betsy Jackes et al., and likewise, identification was carried out by same
group following appropriate guidelines. Voucher specimens were deposited at the James
Cook Herbarium (JCT). The plant material was collected and initial screening was
carried out for biological activities from 100 g finely chopped in ethanol/chloroform (1:1)
at ambient temperature for 48 hours. The plants that showed activity in screening were
extracted by Soxhlet extraction with refluxing chloroform for 4 hours whereas Tabebuia
bahamensis was extracted using acetone as solvent. About 25 g of extract was stored in a
separate bottle to store in a freezer at 4 C for later usage.
2.2 Chromatographic Separation of Drypetes lasiogyna
About 25 g of chloroform bark extract of Drypetes lasiogyna was sub ected to
bioactivity-directed column chromatography using silica (40-63 μm particle size and 60
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porosity) as the stationary phase in a column of length 90 cm (length)

5 cm

(diameter). The elution was further carried out using dichloromethane/ethyl acetate
(EtOAc) step gradient as illustrated in figure 2.1. Each solvent system was used at a
volume of 500 mL to 1L, based on the movement of the extract through column by the
solvent. Subsequently, different fractions were analyzed with thin layer chromatography
(TLC) by spotting few drops of concentrated fraction samples, and viewing the TLC
plates (200 μm thickness) under UV light after developing the plates as shown in figure
2.2. Thus, the fractions with similar retention factor (Rf) value were combined to obtain
super-fractions SF(s). The detailed chromatographic analysis of extracts with the yield is
given in table 2.1 below.
Fractions 5, 6 and 7 (SF A) of vial 6A after running small column using
DCM/EtOAc were combined together and then purified by recrystallization.
Recrystallization was carried out by vapor diffusion method using EtOAc and pentane as
solvents. For this, a small amount of the fraction in a vial was dissolved in small volume
of EtOAc by gentle heating and the vial was placed in a larger vial with pentane. The set
up was kept undisturbed for a few days to obtain crystals of respective fractions. The
crystals were then separated from the supernatant, and those purified crystals were further
dissolved in deuterated solvent (8 mg in 750 μL) for subsequent NMR analysis.
Similarly, Vial 18 of weight about 0.9415 g containing combined fractions of 59
to 65 was sub ected to column chromatography using small column using silica (40-63
μm particle size and 60

porosity) as the stationary phase in a column of length 90 cm

(length) × 5 cm (diameter). The elution was carried out using DCM/ethyl acetate (EtOAc)
step gradient. Furthermore, each solvent system was used at a volume of 50 mL to 100
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mL based on the movement of the fraction through column by the solvent. The different
fractions were further analyzed with thin layer chromatography (TLC) by spotting few
drops of concentrated fraction samples and viewing the TLC plates (200 μm thickness)
under UV light after developing the plates, and then the fractions with similar retention
factor (Rf) value were combined to obtain super-fractions SF(s).
Sub fractions 15, 16 and 17 (SF B) as shown in figure 2.3 of weight 0.3251 g
were combined together followed by purification via recrystallization. Recrystallization
was carried out by vapor diffusion method using EtOAc and pentane as solvents. For this,
a small amount of the fraction in a vial was dissolved in small volume of EtOAc by
gentle heating and the vial was placed in a larger vial with pentane. Also, the set up was
kept undisturbed for a few days to obtain crystals of respective fractions. The crystals
were then separated from the supernatant. Finally, the purified crystals were dissolved in
deuterated solvent (7.5 mg in 750 μL), followed by further NMR analysis.
Likewise, vial 20 containing combined fractions of 67 to 69 of weight about
1.0537 g was subjected to column chromatography using small column using silica (4063 μm particle size and 60

porosity) as the stationary phase in a column of length 90

cm (length) × 5 cm (diameter). The elution was carried out using DCM/ethyl acetate
(EtOAc) step gradient. Each solvent system was used at a volume of 50 mL to 100 mL
based on the movement of the fraction through column by the solvent. The different
fractions were analyzed with thin layer chromatography (TLC) by spotting few drops of
concentrated fraction samples and viewing the TLC plates (200 μm thickness) under UV
light after developing the plates. The fractions with similar retention factor (Rf) value
were combined to obtain super fractions SF(s).
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Sub fractions 15, 16 and 17(SF C) of weight 0.1417g were combined together and
then purification by recrystallization was further carried out. Recrystallization was
performed by vapor diffusion method using EtOAc and pentane as solvents. For this, a
small amount of the fraction in a vial was dissolved in small volume of EtOAc by gentle
heating and the vial was placed in a larger vial with pentane. Moreover, the set up was
kept undisturbed for a few days to obtain crystals of respective fractions, and the crystals
were further separated from the supernatant. Consequently, purified crystals were
procured, and dissolved in deuterated solvent (7.00 mg in 750 μL) for further downstream
analysis using NMR techniques.

Drypetes lasiogyna crude chloroform bark extract (25gm)

DCM/EtOAc

8:2

9:1

F1-29

F30-39

7:3

F59-66

Column chromatography
SiO2 (90cm*5cm)

1:1

F67-80

100%
EtOAc

F80-92

Fig 2.1 Chromatographic Separation Scheme for Drypetes lasiogyna Extracts
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Fig 2.2 TLC Plate under UV Light

Figure 2.3 Crystals of SF B
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Table 2.1 Chromatographic Separation Scheme for Drypetes lasiogyna Extract
Vial

Flasks

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

1-4
5-7
8
9-10
11
12
13-29
30-31
32-33
34-36
37-39
40-41
42
43-44
45-47
48-51
52-54
55-58
59-65
66
67-69
70-76
77
78-81
82-87
88-94
95-96
97-98

(Mass in gram)
Empty vial
12.9942
12.8562
12.8448
12.9866
12.9704
12.9834
12.9063
12.9237
12.9938
12.0396
12.043
12.9795
12.9294
12.8236
13.0043
12.9663
12.8449
12.8364
12.9491
12.8147
12.0048
12.0190
12.0243
12.9399
12.8239
12.9686
12.8751
13.0778

(Mass in gram)
Dried vial
13.1843
13.2827
13.0967
13.9021
13.3471
13.1980
15.7192
13.0977
13.1373
12.2853
12.6078
13.3010
13.1102
13.3394
13.5984
13.9277
13.4579
13.6351
13.8907
13.1812
13.0585
13.4445
12.2917
13.8922
14.3312
14.3116
17.1883
13.3075

(Mass in gram)
Net product
0.1901
0.4265
0.2519
0.9155
0.3767
0.2146
2.8129
0.1740
01435
0.2457
0.5835
0.3125
0.1808
0.5158
0.5941
0.9614
0.6130
0.7987
0.9416
0.3665
1.0537
1.4255
0.2674
0.9523
1.5073
1.3430
4.3132
0.2297

Number of
TLC bands
4
1
6
6
8
4
4
3
2
4
5
6
7
6
8
7
6
4
4
5
4
5
3
4
3
4
5
5

Solvent system

Hexane: EtOAc
9:1

Hexane: EtOAc
8:2

Hexane: EtOAc
7:3

Hexane: EtOAc
1:1
100% EtOAc
100%
MeOH

2.3 Chromatographic Separation of Tabebuia bahamensis
Similarly, bioactivity-directed flash chromatography was carried out on 25 grams
of acetone bark extract from Tabebuia bahamensis using silica (40-63 μm particle size
and 60

porosity) as the stationary phase in a column of length 90 cm (length)

5 cm

(diameter). The elution was further carried out using hexane/EtOAc step gradient as
illustrated in figure 2.4. Each solvent system was used at a volume of 500 mL to 1L
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based on the movement of the column by the solvent. Furthermore, TLC was analyzed on
different fractions, by spotting few drops of concentrated fraction samples, and
subsequently TLC plates were viewed under UV light. Thus, the fractions with similar
retention factor (Rf) value were combined to obtain SFs.
Fractions 7, 8 and 9 (SF D) of weight 0.0426 gram were combined together to
further purify by recrystallization method. Vapor diffusion method was implemented for
recrystallization using EtOAc and solvents, for which, a small amount of the fraction in a
vial was dissolved in small volume of EtOAc by gentle heating, and the vial was placed
in a larger vial with pentane. Also, the set up was kept undisturbed for a few days to
obtain crystals of respective fractions. As a result, the crystals were separated from the
supernatant, and the purified crystals were further dissolved in deuterated solvent (8 mg
in 750 μL) to perform NMR analysis.

Tabebuia bahamensis acetone bark extracts (25gm)

Column chromatography
SiO2 (90cm*5cm)

Hexane: Ethyl acetate

9:1

8:2

F1-29

F30-56

100%
EtOAc

1:1

7:3

F57-82

F83-106

F107-123

Fig.2.4 Chromatographic Separation Scheme for Tabebuia Bahamensis Extracts
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2.4 NMR Experiments
The samples were dissolved in suitable deuterated solvent (7.5 mg in 750 μL) and
NMR experiments were run in Varian INOVA 500 MHz NMR spectrometer. For most of
the samples the following experiments were run:


1



13



Heteronuclear Single Quantum Coherence (HSQC) spectrum



Heteronuclear Multiple Bond Correlation (HMBC) spectrum



Correlation Spectroscopy (COSY) spectrum

H spectrum
C spectrum

The processing and analysis of spectral data were performed by using Mestrenova
software version 10.0.
2.5 IR Experiments
Small amount of crystalline substance was placed in a crystal plate. The
background noise was checked and then pressure was applied to sample. The frequency
was set to 650 cm-1 – 4000 cm-1 with scan number of 32 to get better resolution. The IR
experiments of the pure samples were performed using PerkinElmer Spectrum Two FTIR Spectrometer. The processing and analysis of spectral data were performed by using
Spectrum software version 10.0.
2.6 Antimicrobial Screening
The compounds were screened for antimicrobial activity against Gram-positive
bacteria Bacillus cereus (ATCC No. 14579) and Staphylococcus aureus (ATCC No.
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29213), and Gram-negative bacteria Escherichia coli (ATCC No. 10798). The minimum
inhibitory concentrations (MIC) of the compounds against these microbes were
determined by microbroth dilution technique as demonstrated by Sahm and Washington,
1991. Exactly 50 μL of 1% w/v solutions of the samples in DMSO was put in a well of
96 well plates and 50 μL of cation–adjusted Mueller Hinton broth (CAMHB) was added.
The sample solutions were then serially diluted (1:1) by transferring 50 μL of
sampleCAMHB mixture to the next lane and adding 50 μL fresh CAMHB to obtain
concentration from 2500 μg/mL to 12.5 μg/mL. The microbes were added to each well at
a concentration of approximately 1.5  108 colony forming units (CFU)/mL. The plates
were incubated at 37 C for 24 hours and the final MIC was determined as the lowest
concentration without any turbidity in the solution. Gentamicin was used as positive
antimicrobial control and DMSO was used as negative control.
Antifungal activity of the samples against Candida albicans (ATCC No. 90028)
and Aspergillus niger (ATCC No. 16888) were determined in a similar manner as did for
antibacterial activity assay described earlier , in yeast-nitrogen base growth medium with
final concentration of approximately 7.5  107 CFU/mL. Amphotericin B was used as
positive control and DMSO was used as negative control for antifungal test.
2.7 Cytotoxicity Activity Test
The compound B from Drypetes lasiogyna was screened for cytotoxic activity
against MCF-7, MDA-MB-231, and 5637 cell lines using 96-well using MTT-based
Cytotoxicity Assay (Berridge, Herst, and Tan 2005). MCF-7 human breast
adenocarcinoma cells (ATCC No. HTB-22) and MDA-MB-231 cells (ATCC No. HTB-
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26) were grown in RPMI 1640 supplemented with 10% Fetal bovine serum (FBS), 30
mM HEPES, NaHCO3, and Penicillin-Streptomycin. 5637 human bladder cancer cells
(ATCC No. HTB-9) were grown in RPMI 1640 supplemented with 10% FBS, 1 mM
sodium pyruvate, 2.5 g/L glucose, 30 mM HEPES, NaHCO3, and Penicillin
Streptomycin. Cells were plated into 96-well cell culture plates at concentration of 2.5
×104cells/well. The volume in each well was 100 μL. After 48 hours, supernatant fluid
was removed by suction and replaced with 100 μL growth medium containing 1.0 μL of
DMSO solution of the sample (1% w/w in DMSO), giving a final concentration of 100
μg/mL for each well. Solutions were added to wells in four replicates. Medium controls
and DMSO controls (10 μL DMSO/mL) were used. Tingenone was used as a positive
control. After the addition of compounds, plates were incubated for 48 h at 37°C in 5%
CO2; medium was then removed by suction, and 100 μL of fresh medium was added to
each well. In order to establish percent kill rates, the MTT assay for cell viability was
carried out (Ferrari, Fornasiero, and Isetta 1990). After colorimetric readings were
recorded using SpectraMAX Plus microplate reader, at 570 nm, percent kill was
calculated.
Both antimicrobial and Cytotoxicity screenings were performed by Noura Dosoky
of the Natural Products Drug Discovery Research group.
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CHAPTER 3
RESULT

3.1 Compounds Isolated from Drypetes lasiogyna
3.1.1 Characterization of SF A
Colorless white crystal was obtained from super fraction A. NMR analysis and
comparison to the literature led to the conclusion that compound A is friedelin with
chemical structure as shown in figure 3.1.

Fig 3.1 Chemical Structure of friedelin
Molecular formula: C30H50O
Molecular weight: 426.7 g/mol
Yield: 0.4265 g
%Yield: 1.70 %
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1

H NMR (499.9 MHz, Chloroform-d): δ 2.44 – 2.37 (m, 1H), 2.35 – 2.22 (m,

2H), 2.03 – 1.93 (m, 1H), 1.80 – 1.74 (m, 1H), 1.73 – 1.65 (m, 1H), 1.59 – 1.58 (m, 1H),
1.57 – 1.54 (m, 2H),1.53 – 1.43 (m, 5H), 1.42 – 1.34 (m, 7H), 1.31 – 1.21 (m, 4H), 1.19
(s, 3H), 1.06 (s, 3H), 1.02 (s, 3H), 1.01 (s, 3H), 0.96 (s, 3H), 0.95 – 0.93 (m, 1H), 0.89
(s,3H)0.88 (s, 3H), 0.73 (s, 3H).
The proton spectrum shows a bunch of peaks in the range of 0.7 ppm to 2.5 ppm
indicating a sterol or a terpenoid. The peaks in the range of 2 to 2.5 ppm indicate the
protons HC-COOH or HC-COOR or HC-C=O. Peaks at 1.19 ppm, 1.06 ppm, 1.02 ppm,
1.01 ppm, 0.96 ppm, 0.89 ppm, 0.88 ppm, 0.73ppm corresponds to the methyl groups (as
illustrated in figure3.2 and 3.3). The solvent peak is at 7.27 ppm which is chloroform.
13

C NMR (125.7 MHz, CDCl3): δ 213.61, 77.16, 59.88, 58.63, 53.51, 43.20,

42.55, 41.94, 41.70, 40.10, 39.66, 38.70, 37.85, 36.42, 36.03, 35.75, 35.43, 33.18, 32.83,
32.50, 32.19, 30.91, 30.40, 28.58, 22.69, 20.67, 19.07, 18.64, 18.35, 15.07, 7.23.
Carbon spectrum shows total of 30 carbon peaks. Peak at 213.36 ppm indicates
the presence of -C=O functionality as shown in figure 3.4 . The peak at 77.16 indicates
the CDCl3 peak.
The 1H and

13

C and HSQC Spectrum (figure 3.5) of friedelin is in accordance

with the values provided in the literature (Akisha et al., 1992; Castola et al., 2002; Ghos
et al., 2010). The detailed NMR analysis is shown in table 3.1 below.
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Table 3.1 NMR Assignment of friedelin
Position

Carbon δ 13C (ppm)

Function

Proton δ 1H (ppm)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

22.69
41.94
213.61
58.63
42.55
41.70
18.64
53.51
37.85
59.88
36.03
30.91
40.10
38.70
32.83
36.42
30.40
43.20
35.75
28.58
33.18
39.66
7.23
15.07
18.35
20.67
19.07
32.50
35.43
32.19

CH2
CH2
quat
CH
quat
CH2
CH2
CH
quat
CH
CH2
CH2
quat
quat
CH2
CH2
quat
CH
CH2
quat
CH2
CH2
CH3
CH3
CH3
CH3
CH3
CH3
CH3
CH3

1.68, 1.97
2.32, 2.39
2.26
1.29, 1.77
1.36, 1.49
1.40
1.55
1.27, 1.47
1.35 (2H)
1.35, 1.51
1.38, 1.58
1.55
1.24, 1.36
1.28, 1.46
0.94, 1.52
0.89 (s)
0.73 (s)
0.88 (s)
1.02(s)
1.06(s)
1.19(s)
0.96(s)
1.01 (s)
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Fig 3.2 Proton NMR Spectrum of friedelin
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Fig 3.3 Proton NMR Spectrum of friedelin (Zoomed)
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Fig 3.4 Carbon Spectrum of friedelin
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Fig 3.5 13C- HSQC Spectrum of friedelin
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3.1.2 Characterization of SF B
From super fraction B, white crystalline compound was obtained. Analysis of
NMR spectra led to the conclusion that compound B is5α-dammar-20-ene-3β,24,25-triol
with chemical structure as shown in figure 3.6.

Fig 3.6 Chemical Structure of 5α-dammar-20-ene-3β,24,25-triol
Molecular formula: C30H52O3
Molecular weight: 426.7 g/mol
Yield: 0.4265 g
% Yield: 1.70 %
1

H NMR (499.9 MHz, Chloroform-d): δ1H NMR (500 MHz, Chloroform-d) δ

4.78 (s, 1H), 4.73 (d, J = 1.35 Hz, 1H), 3.41 (d, J = 10.05 Hz, 1H), 3.19 (dd, J = 4.9,
11.55 Hz, 1H), 2.28 – 2.16 (m, 2H), 2.08 – 2.01 (m, 1H), 1.89 (s, 1H), 1.72 – 1.57 (m,
10H), 1.49 – 1.40 (m, 3H), 1.33 – 1.25 (m, 3H), 1.22 (s, 3H), 1.17 (s, 3H), 1.15 – 0.99
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(m, 3H), 0.98 (s, 6H), 0.87 (s, 3H), 0.85 (s, 3H), 0.78 (s, 3H), 0.74 (dd, J = 2.15, 11.55,
1H).
The protons with chemical shifts of 4.78 and 4.73 ppm represent the olefenic
protons (-CH=CH2). The protons with chemical shifts of 3.49 and 3.19 ppm represent the
protons directly attached to C-O carbon. There are seven methyl singlets at δ 0.78, 0.85,
0.87, 0.98, 0.98, 1.17 and 1.22 ppm determined on the basis of integration. The proton
spectrum is shown in figure 3.9 and 3.10 The peak at 7.26 ppm is the chloroform solvent
peak.
13

C NMR (125.7 MHz, CDCl3): δ 15.79, 16.07, 16.34, 16.66, 18.70, 21.75, 23.67,

25.39, 26.97, 27.83, 28.43, 29.64, 30.50, 31.80, 31.95, 35.83, 37.63, 39.39, 39.51, 40.88,
46.05, 48.20, 49.88, 51.32, 56.28, 73.55, 77.16, 78.78, 79.36, 108.12, 153.26.
There are total of 30 peaks indicating 30 carbons. The chemical shifts of 153.26
and 108.12 ppm represent the olefinic carbons (-C=C-). The chemical shift of 79.36,
78.78 and 73.55 ppm represents the carbons bonded to hydroxyl group (-C-OH). The
peak at 77.16 is the chloroform solvent peak. The Carbon spectrum is shown in figure
3.11 and 3.12 below.
The HSQC spectrum in (fig 3.13) shows 11 methylene (–CH2) functionalities at δ
18.70, 21.75, 26.97, 27.83, 29.64, 30.50, 31.80, 31.95, 35.83, 39.51, 108.12 ppm and 6
methine functions (-CH) at δ 46.05, 48.20, 51.32, 56.28, 79.36, 78.78. 6 quaternary
carbons are indicated by carbon chemical shift value at δ 37.63, 39.39, 40.88, 49.88,
73.55 and 153.26 ppm whereas 7 methyl groups (-CH3) showed carbon at δ 15.79, 16.07,
16.34, 16.66, 23.67, 25.39 and 28.43 ppm. COSY spectrum (figure 3.14) show the
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linking of proton at 1.57 ppm with the proton at 3.20 ppm. Final correlation has been
done by looking H C connections from HMBC spectrum (figure 3.15) as shown by
arrows in figure 3.7 below.

Fig 3.7 Key HMBC Correlations of 5α-dammar-20-ene-3β,24,25-triol
IR Spectra ʋKBr max (fig 3.15):3380.12 cm-1 , 2960.47 cm-1, 2857.68 cm-1 ,
1633.59 cm-1 , 1446.54 cm-1 , 1413.16 cm-1 1384.92 cm-1 , 1359.98 cm-1, 1299.14 cm-1,
1245.37 cm-1, , 1083.18 cm-1 , 1047.76 cm-1, 985.93 cm-1 , 940.81 cm-1 , 886.05 cm-1 ,
783.49 cm-1, 709.57 cm-1. The IR spectrum is shown in figure 3.16 below.
The 1H, 13C and IR Spectra of 5α-dammar-20-ene-3β,24,25-triol is in accordance
with the values provided in the literature (Sheingthong et al., 1974; Boar and Damps,
1977; Yodsaoue et al., 2012). The detailed NMR analysis is shown in table 3.2 below.
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Table 3.2 NMR Assignment of 5α-dammar-20-ene-3β, 24, 25-triol
Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Carbon δ
13
C (ppm)
39.51
27.83
79.36
39.39
56.28
18.70
35.83
40.88
51.32
37.63
21.75
25.39
46.05
49.88
31.80
29.64
47.69
16.07
16.66
153.26
108.12
31.95
30.50
78.78
73.55
26.97
23.67
28.43
15.79
16.34

Proton δ
1
H (ppm)
1.00, 1.71
1.57, 1.62
3.19 (dd, J= 4.9, 11.35 Hz)
0.74 (dd, J= 2.15, 11.58 Hz)
1.45, 1.55
1.28, 1.58
1.32
1.30, 1.57
1.08, 1.57
1.68
1.11, 1.62
1.41, 1.92
2.20
0.98 (s)
0.85(s)
4.73(d, J = 1.35 Hz), 4.78 (s)
2.05, 2.28
1.48, 1.68
3.41(d, J = 10.05 Hz)
1.22 (s)
1.17 (s)
0.98 (s)
0.78 (s)
0.87 (s)

Type

Connected 1H

CH2
CH2
CH
quat
CH
CH2
CH2
quat
CH
quat
CH2
CH2
CH
quat
CH2
CH2
CH
CH3
CH3
quat
CH2
CH2
CH2
CH
quat
CH3
CH3
CH3
CH3
CH3

3, 9, 19
1
2a, 2b, 28, 29
2, 3, 28, 29
1, 19, 28,29
5, 6, 18
7a, 7b, 9, 18, 30
5, 6a, 6b, 7, 18, 19
2a, 2b, 5, 9, 19
12, 13
11, 13, 17
11,12, 15, 17, 30
13, 15a, 15b, 16, 18, 30
16, 30
15, 17
13, 15, 16, 21a,21b, 22a, 22b
15
16, 17, 21a, 21b, 22a, 22b, 23a, 23b
17, 22a, 22b
17, 21a, 21b, 23
22a, 22b
22a, 22b, 26, 27
26, 27
27
26
3, 5, 29
3, 5
9

The molecule contain dammarane ring structure rather than protostane as comparision of
carbon chemical shifts at C-1, C-5, C-9 and C-17 of 24(S),25-epoxy-5α-dammar-20-dien-3onehas higher value by about 5-10 ppm than 24(S),25- epoxy-5α-protost-20,25-dien-3-one
whereas carbon chemical shift at C-19 of the protostane ring containing 24(S),25-epoxy-5α-
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protost-20,25-dien-3-one is higher than that of the dammarane skeleton by about 6–8 ppm. Our
molecule shows in accordance with the dammarane ring value (Yodsaoue et al., 2012).
The biosynthesis pathway of the molecule(as shown in figure 3.8) is likely to be derived
from the common 2, 3(S);22(S),23-diepoxysqualene through cyclization via a chair/chair/chair
conformation of the potential A/B/C ring system resulted in a trans/anti/trans ring junction
(A/B/C) of a dammarane triterpene.

Fig 3.8 Plausible Biosynthesis Pathway (Yodsaoue et al., 2012)
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Fig 3.9 Proton Spectrum of 5α-dammar-20-ene-3β,24,25-triol
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3.10 Proton Spectrum of 5α-dammar-20-ene-3β,24,25-triol (Zoomed)

63

Fig 3.11 Carbon Spectrum of 5α-dammar-20-ene-3β,24,25-triol (Full)
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Fig 3.12 Carbon Spectrum of 5α-dammar-20-ene-3β,24,25-triol (Zoomed)
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Fig 3.13 13C- HSQC Spectrum of 5α-dammar-20-ene-3β,24,25-triol
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Fig 3.14 COSY Spectrum of 5α-dammar-20-ene-3β,24,25-triol
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Fig 3.15 HMBC Spectrum of 5α-dammar-20-ene-3β,24,25-triol
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Fig 3.16 IR Spectrum of 5α-dammar-20-ene-3β, 24, 25-triol
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3.1.3 Characterization of SF C
From superfraction C, white crystalline powder compound was obtained. Analysis
of NMR spectra led to the conclusion that compound C is dammar-20-ene-24, 25-diol-3yl caffeate with chemical structure as shown in figure 3.17.

Fig 3.17 Chemical Structure of dammar-20-ene-24,25-diol-3-yl caffeate
1

H NMR (500 MHz, Chloroform-d): δ7.55 (d, J = 15.9 Hz, 1H), 7.09 (d, J = 1.9

Hz 1H), 7.00 (dd, J = 1.85, 8.30 Hz, 1H), 6.88 (d, J = 8.2 Hz, 1H), 6.28 (d J = 15.9 Hz,
1H), 4.79 (s, 1H), 4.73 (d, J = 1.05 Hz, 1H) 4.62 (dd, J = 5.57, 10.57 Hz, 1H), 3.41 (dd, J
= 1.72, 10.47 Hz, 1H), 2.18- 2.29 (m., 1H), 1.99- 2.08 (m,1H), 1.91- 1.96 (m, 1H), 1.74 –
1.48 (m, 11H), 1.45 – 1.28 (m, 5H), 1.24 (s, 3H), 1.19 (s, 3H), 1.16 – 1.06 (m, 3H), 0.98
(s, 3H), 0.93 (s, 3H), 0.89 (s, 6H), 0.88 (s, 3H), 0.87 (m, 1H).
Proton chemical shift value between 7-8 ppm indicates the presence of aromatic
ring. Proton chemical shift value of 6.88 indicates that it is attached with highly
electronegative environment.The protons with chemical shifts of 4.78 and 4.73 ppm
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represent the olefenic protons (-CH=CH2). The protons with chemical shifts of 4.62 and
3.41 ppm represent the protons directly attached to C-O carbon, where chemical shift of
value 4.62 indicates the attchement of carbon with electronegative group in
electronegative environment. There are seven methyl singlets at δ 0.87, 0.89, 0.89, 0.93,
0.98, 1.19 and 1.24 ppm determined on the basis of integration as shown in figure 3.19
and 3.20 whereas the peak at 7.26 ppm indicates the chloroform solvent peak.
13

C NMR (126 MHz, cdcl3): δ 15.57, 15.83, 16.21, 16.59, 18.09, 21.27, 23.14,

23.74, 24.85, 26.45, 27.96, 29.11, 29.96, 31.30, 31.38, 35.25, 37.06, 38.06, 38.69, 40.40,
45.54, 47.69, 49.38, 50.72, 55.89, 73.19, 77.16, 78.33, 80.93, 107.68, 114.23, 115.36,
116.32, 122.23, 127.63, 143.70, 144.21, 146.03, 152.69, 167.33
There are total of 39 peaks indicating 39 carbons. The chemical shifts of 153.26
and 108.12 ppm represent the olefinic carbons (-C=C-). The chemical shift of 80.93,
78.33 and 73.19 ppm represents the carbons bonded to hydroxyl group (-C-OH). The
peak at 77.16 is the chloroform solvent peak. The carbon spectrum is shown in figure
3.21. COSY spectrum (figure 3.24) shows the link of proton at 7.55 ppm with 6.28 ppm
and proton at 3.41 ppm with 1.48 ppm.
The HSQC spectrum in (figure 3.22, 3.23) shows 11 methylene (–CH2)
functionalities at δ 18.70, 21.75, 26.97, 27.83, 29.64, 30.50, 31.80, 31.95, 35.83, 39.51,
108.12 ppm and 6 methine functions (-CH) at δ 46.05, 48.20, 51.32, 56.28, 79.36, 78.78.
6 quaternary carbons are indicated by carbon chemical shift value at δ 37.63, 39.39,
40.88, 49.88, 73.55 and 153.26 ppm whereas 7 methyl groups (-CH3) showed carbon at δ
15.79, 16.07, 16.34, 16.66, 23.67, 25.39 and 28.43 ppm. Final correlation has been done

71

by looking H C connections from HMBC spectrum as shown by arrows in figure 3.18
below. The detailed NMR analysis is shown in table 3.3 below.

Fig 3.18 Key HMBC Correlations of dammar-20-ene-24,25-diol-3-yl caffeate
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Table 3.3 NMR Assignment of Dammar-20-ene-24,25-diol-3-yl caffeate
Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39

Carbon δ 13C
(ppm)
38.69
23.74
80.93
38.06
55.89
18.09
35.25
40.40
50.72
37.06
21.27
24.85
45.54
49.38
31.30
29.11
47.69
15.83
16.21
152.69
107.68
31.38
29.96
78.33
73.19
26.45
23.14
27.96
16.59
15.57
167.33
116.32
144.21
127.63
114.21
143.70
146.03
115.36
122.23

Proton δ 1H
(ppm)
1.07, 1.72
1.57, 1.62
4.62 (dd, J = 5.57,10.57 Hz)
0.87
1.45, 1.55
1.28, 1.59
1.32
1.34, 1.51
1.08, 1.57
1.67
1.11, 1.61
1.41, 1.92
2.20
0.98 (s)
0.89 (s)
4.73(d, J= 1.05 Hz), 4.79 (s)
2.05, 2.26
1.48, 1.66
3.41(d,J = 1.72,10.47 Hz)
1.24(s)
1.19(s)
0.89(s)
0.93(s)
0.88(s)
6.28(d, J = 15.9 Hz)
7.55(d, J = 15.9 Hz)
7.09(d, J = 1.9 Hz)
6.88(d, J = 8.2 Hz)
7.00(dd, J = 1.85,8.30 Hz)
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Type

Connected 1H

CH2
CH2
CH
quat
CH
CH2
CH2
quat
CH
quat
CH2
CH2
CH
quat
CH2
CH2
CH
CH3
CH3
quat
CH2
CH2
CH2
CH
quat
CH3
CH3
CH3
CH3
CH3
quat
CH
CH
quat
CH
quat
quat
CH
CH

9, 19
3
2a, 2b, 28 or 29
3, 28, 29
1, 29
6, 18
7a, 7b, 9, 18, 30
19, 30
2a, 2b, 9, 19
9, 12
11, 13, 17
17, 18
18, 30
16, 30
15, 17
12, 15, 21a, 21b
15
16, 17, 21a, 21b, 22a, 22b, 23a, 23b
17, 22a, 22b
21a, 21b, 24
22a, 22b,24
22a, 22b, 26, 27
24, 26, 27
27, 15
24, 26
3, 29
3, 5, 28
3, 32, 33
33
35, 39
32, 38
33, 39
38
35, 38, 39
33, 35, 38

Fig 3.19 Proton Spectrum of dammar-20-ene-24, 25-diol-3-yl caffeate
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Fig 3.20 Proton Spectrum of dammar-20-ene-24, 25-diol-3-yl caffeate (Zoomed)
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Fig 3.21 Carbon Spectrum of dammar-20-ene-24, 25-diol-3-yl caffeate
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Fig 3.22 13C- HSQC Spectrum of dammar-20-ene-24,25-diol-3-yl caffeate
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Fig 3.23 13C- HSQC Spectrum of dammar-20-ene-24,25-diol-3-yl caffeate (Zoomed)
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Fig 3.24 COSY Spectrum of dammar-20-ene-24,25-diol-3-yl caffeate
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Fig 3.25 HMBC Spectrum of dammar-20-ene-24,25-diol-3-yl caffeate
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3.2 Compound from Tabebuia bahamensis
Characterization of SF D
From superfraction D, white crystalline compound was obtained. Analysis of
NMR spectra led to the conclusion that compound D is taraxeryl acetate with chemical
structure as shown in figure 3.26.

Fig 3.26 Chemical Structure of taraxeryl acetate
Molecular formula: C32H52O2
Molecular weight: 468.75408 g/mol
Yield: 0.4265 g
%Yield: 1.70 %
1

H NMR (499.9 MHz, Chloroform-d) : δ 5.54 (dd, 1H), 4.44 (q, 1H), 2.05 (s, 1H),

2.04 (s, 3H), 1.93 – 1.58 (m, 9H), 1.48 – 1.27 (m, 8H), 1.09 (s, 3H), 1.05 – 0.97 (m, 4H),
0.95 (s, 6H), 0.91 (s, 3H), 0.90 (s, 3H), 0.88 (m,1H) 0.88 (s, 3H ) 0.86 (s, 3H), 0.82 (s,
3H).
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The proton chemical shift of 5.54 ppm indicates the presence the olefenic protons
(-CH=CH2). The 4.44 ppm indicates the proton directly attached to C-O carbon in a
highly electronegative environment. There are 9 methyl peaks with 0.82, 0.86, 0.88, 0.91,
0.91, 0.95, 0.95, 1.09 ppm and value of 2.04 ppm is for methyl functionality (figure 3.27
and 3.28) of acetate group whereas the peak at 7.26 ppm indicates the chloroform solvent
peak.
13

C NMR (125.7 MHz, CDCl3) : δ 171.39, 158.38, 117.34, 81.43, 77.16, 56.05,

49.60, 49.17, 41.63, 39.39, 38.30, 38.10, 38.09, 37.96, 37.80, 37.07, 36.19, 35.52, 34.09,
33.76, 33.50, 30.33, 30.24, 29.21, 28.39, 26.33, 23.87, 21.73, 21.69, 19.10, 17.92, 17.00,
15.91
The molecule has 32 peaks, which indicates the presence of 32 carbons. Carbon
chemical shift of 171.39 ppm indicates the ester linkage whereas 158.38 and 117.34 ppm
represent the olefinic carbons (-C=C-). Similarly, chemical shift of 81.43 ppm represents
the carbons bonded to hydroxyl group (-C-OH) as shown in figure 3.29, where the peak
at 77.16 indicates the chloroform solvent peak.
The HSQC spectrum in (fig 3.30) shows 10 methylene (–CH2) functionalities at δ
17.92, 19.10, 23.87, 33.50, 34.09, 35.52, 37.09, 37.80, 38.10, 41.63 ppm and 5 methine
functions (-CH) at δ 49.17, 49.60, 56.05, 81.43, 117.34. Similarly, 8 Quaternary carbons
are indicated by carbon chemical shift value at δ 29.21, 36.19, 37.96, 38.09, 38.30, 39.39,
158.38, 171.39 ppm whereas 9 methyl groups (-CH3) showed carbon at δ 15.91, 17.00,
21.69, 21.73, 6.33, 28.39, 30.24, 30.33, 33.76 ppm. The NMR analysis is given in table
3.4.
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Table 3.4 NMR Assignment of taraxeryl acetate
Position

Carbon δ 13C
(ppm)

Function

Proton δ 1H
(ppm)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32

37.80
23.87
81.43
37.96
56.05
19.10
41.63
39.39
49.60
38.30
17.92
34.09
38.09
158.38
117.34
38.10
36.19
49.17
37.09
29.21
33.50
35.52
28.39
17.00
15.91
26.33
21.69
30.24
33.76
30.33
171.39
21.73

CH2
CH2
CH
quat
CH
CH2
CH2
quat
CH
quat
CH2
CH2
quat
quat
CH
CH2
quat
CH
CH2
quat
CH2
CH2
CH3
CH3
CH3
CH3
CH3
CH3
CH3
CH3
quat
CH3

1.04, 1.60
1.64, 1.64
4.40 (dd, J = 5.52, 10.62 Hz)
0.88
1.48, 1.61
1.37, 2.05
1.46
1.47, 1.64
1.57, 1.63
5.54 (dd, J = 3.2, 8.2 Hz)
1.64, 1.93
0.97
0.98, 1.32
1.26, 1.36
1.02, 1.37
0.86 (s)
0.88 (s)
0.95 (s)
1.09 (s)
0.90 (s)
0.82 (s)
0.95 (s)
0.91 (s)
2.04 (s)
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Fig 3.27 Proton Spectrum of taraxeryl acetate

84

Fig 3.28 Proton Spectrum of taraxeryl acetate (Zoomed)
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Fig 3.29 Carbon Spectrum of taraxeryl acetate
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Fig 3.30 13C- HSQC Spectrum of taraxeryl acetate
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3.3 Results of Antimicrobial Screening
Table 3.5 Antimicrobial Activity Sample Compounds
E. coli
2500

Antimicrobial Activity (MIC, μg/mL)
B. cereus
S. aureus
C. albicans
625
1250
2500

A. niger
2500

5α-Dammar-20-ene3β,24, 25-triol

2500

2500

2500

2500

2500

Dammar-20-ene-24,25diol-3-yl caffeate

312.5

2500

312.5

1250

2500

Taraxeryl acetate

2500

2500

2500

19.5

2500

Compounds
Friedelin

3.4 Results of Cytotoxic Assay
Table 3.6 MTT Cytotoxicity Assays
MTT Cytotoxicity (% kill at 100 μg/mL)

Compounds

Friedelin
5α-Dammar-20-ene3β,24,25-triol
Dammar-20-ene-24,25diol-3-yl caffeate
Taraxeryl acetate
a

MCF-7

MDA-MB-231

5637

11.62 ± 6.1a

0

25.50 ± 11.5

89.65 ± 11.9

97.77 ± 4.1

100

0

0

0

26.10 ± 4.8

10.92 ± 3.6

37.28 ± 4.7

Standard Deviation(SD)

3.5 Molecular Docking
Protein-ligand docking was carried out using Molegro Virtual Docker (Molegro,
2013; Thomsen R. and Christensen M.H., 2006) based on the crystal structures of
farnesyl protein transferase (PDB 1JCQ (Long et al., 2001), topoisomerase II (PDB

88

1QZR (Classen et al., 2003) and PDB 2RGR (Dong K.C. and Berger J.M., 2007 ), DNA
polymerase β (PDB 2BPC (Sawaya et al., 1994) and PDB 3UXN (Gridley et al., 2013),
and 5-lipoxygenase (PDB 3V99 (Gilbert et al., 2012). Prior to docking all solvent
molecules and the co-crystallized ligands were removed from the protein structures. The
ligand structures were built using Spartan ‘14 for Windows (Spartan, 2014). For each
ligand, a conformational search and geometry optimization was carried out using the
MMFF force field (Halgreen, 1996). Molecular docking calculations for each protein
were carried out with a sphere large enough to accommodate the substrate binding cavity
(15 Å radius) to allow each ligand to search for possible docking conformations.
Standard protonation states based on neutral pH were used throughout. Charges were
assigned on each protein based on templates included in the library files of Molegro
Virtual Docker. Flexible ligand models were used in the docking and subsequent
optimization. Variable orientations of each ligand were searched and ranked based on
their re-rank score. For each docking simulation the maximum number of iterations for
the docking algorithm was set to 1500, with a maximum population size of 50, and 30
runs per ligand. The RMSD threshold for multiple poses was set to 1.00 Å.

The

generated poses from each ligand were sorted by the calculated re-rank score.
A molecular docking analysis has been carried out in order to provide some
insight into the possible mechanism of cytotoxic activity of 5α-Dammar-20-ene-3β,24,25triol ( aglaitriol). Both (24R) and (24S) epimers of aglaitriol were examined in the docking

analysis. Ursolic acid, which is known to be an inhibitor of DNA polymerase β,
lipoxygenase, and topoisomerase II (Setzer W.N and Setzer M.C., 2003), was included in
the docking analysis for comparison (table 3.7). Both epimers of aglaitriol docked to the
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protein targets better (more exothermic) than the virtual positive control, ursolic acid.
The protein-ligand interaction with the most exothermic docking energy was the DNA
binding site of topoisomerase II, suggesting that this may be an important target in the
cytotoxic activity of aglaitriol.
Table 3.7 MolDock Rerank Docking Scores for aglaitriol with Protein Targets.

Ligand

Farnesyl protein
transferase

Topoisomerase II

DNA Polymerase β

5-Lipoxygenase

1JCQ

1QZR
ATP site

2RGR
DNA site

2BPC

3UXN

3V99

24R-Aglaitriol

-87.5

-77.7

-194.6

-97.0

-89.9

-107.8

24S-Aglaitriol

-99.4

-73.4

-207.9

-88.5

-79.1

-107.3

Ursolic acid

-78.5

-57.7

-149.6

-73.4

-70.9

-79.8
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CHAPTER 4
DISCUSSION

Friedelin is a pentacyclic triterpenoid that has been isolated most abundantly from
cork and cork-derived materials (e. g., black condensate) extracts obtained from Quercus
suber L. cork tree bark (Patra and Chaudhuri, 1987; Castola et al., 2002; Ghos et al.,
2010). It has also been extracted and identified from extracts of other plants including
Lingnania chungii McClure (Gramineae), Maytenus ilicifolia Mart. ex. Reiss
(Celastraceae), Azima tetracantha Lam. (Salvadoraceae) (Akihisa et al., 1992; Queiroga
et al, 2000; Sunil et al., 2013), and is also known as 3-friedelanone, friedoolenan-3-one.
Friedelin has also been mentioned to be used as herbicides since being inhibitors
of photosynthesis (Castola et al., 2002). Its phytotoxic activity have also been
investigated by applying solution with different concentration to check germination of
both root and shoot of the germinating seeds of wheat, rice and pea brought from local
market in North Bengal, India, and subsequently was found to inhibit the germination of
both root and shoot (Ghos et al., 2010).
Furthermore, this compound has been shown to exhibit potent in-vivo antiinflammatory, analgesic and antipyretic effects (Antonisamy et al., 2011). Likewise, it
has shown to possess remarkable antioxidant, free radical scavenging and liver protective
effects both in vitro and in vivo studies, and also are found to avert or retard the progress
of various oxidative stress-related diseases (Sunil et al., 2013). Further, Wang et al., 2014
reported antibacterial activities against E. coli and M. tetragenus with the MIC values of
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5μg/mL along with Ciprofloxacin as a positive control with the same MIC values of
0.313 μg/mL.
Moreover, being a natural compound with promising properties, Friedelin and its
derivative have been shown to accumulate relevant biological activities. In addition, a
friedelin derivative, 2,3-secofriedelin-2-al-3-oic acid have been reported to possess
inhibitory action on developing breast, lung, renal, melanoma and central nervous system
cancer cells (Moiteiro et al., 2001). Similarly, another friedelin derivative, 3-nor-2,4secofriedelan-4-oxo-2-oic acid has also been reported to have inhibitory characteristics in
the growth of breast, lung, renal, melanoma and central nervous system cancer cells
(Moiteiro et al., 2004). Also, its derivative as agrochemicals for crop protection have
shown to possess remarkable property against S. littoralis and L. decemlineata (Moiteiro
et al., 2006). Furthermore, 3D molecular docking of oxygenated friedelin derivatives in
the central catalytic domain of DNA topoisomerase IIα (1 bgw for topoisomerase IIα,
PDB) have shown inhibitory activity by binding with enzyme, which has been further
confirmed by in vitro experiments (Mandal et al., 2012).
In the current study, friedelin was found to show mild activity against gram
positive bacteria B. cereus and S. aureus however did not show activity against gram
negative bacteria E. coli and also with fungi species involved in the study C. albicans and
A. niger.
The molecule 5α-dammar-20-ene-3β,24,25-triol was first extracted from the light
petroleum extracts of leaves of Aglaia odorata by Sheingthong et al., 1974 where the
structure was further validated by acetylation, followed by hydrolysis yielding the same
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molecule with the spectroscopic data. Later, Boar and Damps, 1977 also synthetically
prepared the same molecule from the compound 24,25-epoxy-5α-dammar-20-en-3-one
isolated from powdered dried leaves of A. odorata and confirmed by spectroscopic data.
Along with other dammarane ring containing triterpenoids and protostane
triterpenoid, Yodsaoue et al., 2012 also isolated 5α-dammar-20-ene-3β,24,25-triol from
CH2Cl2 and MeOH extracts of the leaves of A. odorata separated by vacuum liquid
chromatography (VLC). The anti-inflammatory activities were calculated as inhibitory
activities against lipopolysaccharide (LPS) induced nitric oxide (NO) production in
mouse macrophage cell line (RAW264.7) using indomethacin as positive control which
has shown to be less active with IC50 of 16.8.
In the current in vitro study, 5α-dammar-20-ene-3β,24,25-triol showed potent
cytotoxic activity against human bladder carcinoma cell line (5637), human breast
adenocarcinoma cell line (MCF-7), human breast adenocarcinoma (MDA-MB-23) with
% kill of value 100, 89.65 and 97.77, respectively. The antimicrobial screening against E.
coli, B. cerus, S. aureus, C. albicans and A. niger did not show good activity.
The molecules containing dammarane ring attached with caffeoyl structure such
as dammarendiol II 3-O-caffeate, ocotillol II 3-O-caffeate along with other compounds
extracted from root bark of Betula platyphylla var. japonica have been reported by
Fuchino et al., 1996. In the current study, dammar-20-ene-24, 5-diol-3-yl- caffeate has
been first time extracted from Drypetes lasiogyna, where this molecule showed activity
against S. aureus and B. cerus with IC50 value of 312.50 μg/mL, whereas it showed mild
activity against C. albicans and no activity against B. cerus and A. niger.
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Taraxeryl acetate is a pentacyclic triterpenoid with molecular formula C32H52O2
possessing molecular weight 468.761 amu., which have been most widely extracted from
plants including different family such as Euphorbia maculata(Euphorbecacea), Hibiscus
rosasinensis Linn. (Malvaceae), Phyllanthus reticulatus(Euphorbecacea), Taraxacum
japonicum (Asteraceae), Laggera pterodonta (DC.) Benth. (Asteraceae), Ficus ovata
(Moraceae), Cissus quadrangularis (Vitaceae) (Matsunaga et al., 1988; Takasaki et al.,
1999; Gilani et al., 2005; Begum et al., 2006; Kuljanabhagavad et al., 2009; Kuete et al.,
2009; Mishra et al., 2010). It is also known as D-Friedoolean-14-en-3β-yl acetate, acetyl
taraxerol, taraxerol monoacetate.
Moreover, taraxeryl acetate has been shown to exhibit antiviral activity against
herpes simplex virus (HSV) type II, with EC50 of 50 μg/ml, however, it was found to be
inactive against two human cancer cell lines KB and BC IC50 greater than 50 μg/ml. The
antiviral and cytotoxic activities have been determined using cytopathic effect (CPE)
assay. On the other hand, taraxerone containing same ring system as taraxeryl acetate
have been found to possess weak activity against in herpes simplex virus (HSV) type I
and II, and thus, intact ring A with C-3 acetate group was suggested to be important for
antivirus activities of these compounds (Kuljanabhagavad et al., 2009). However, on the
contrary, Takasaki et al., 1999 compared to its parent molecule taraxerol, taraxeryl
actetate have shown a lower inhibitory effect of human gastric epithelial cell line AGS
cells with the tendency of G(2)/M arrest and apoptosis promotion with no significance
(P>0.05) (Tan B et al., 2011). Similarly, on screening for inhibitory effects on EpsteinBarr virus early antigen (EBV-EA) induced by TPA, in Raji cells as a primary screening
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for cancer preventive agents, it exhibited some poorer activity compared to parent
taraxerol.
Furthermore, Kuete et al., 2009 carried out the antimicrobial activity test of
taraxeryl acetate obtained from methanolic extract of Ficus ovata using micro-dilution
method has been implemented to calculate minimal inhibition concentration (MIC), and
minimal microbicidal concentration (MMC) against few species of Gram-positive and
Gram-negative bacteria along with fungi using gentamycin and nystatin as reference
compounds. Consequently, it has been observed to show noticeable effect against E. coli,
B. cereus, S. aureus, C. albicans and Microsporum audouinii with Minimal inhibition
concentration (μg/ml) value of 78,156,78,156 and 78, whereas minimal microbicidal
concentration (μg/ml) value of 312, 625, 156, 312 and 156 respectively.
Likewise, Rehman et al., 2013 found significant inhibitory activity against both
Cycloxygenase enzymes, COX-1 and COX-2, with IC50: 116.3 ± 0.03 μM and IC50: 94.7
± 0.02 μM, respectively using in-vitro enzyme inhibition assay where molecular docking
result was also in accordance with the assay result showing significant interactions of
taraxerol acetate with the important amino acid residues surrounding the inhibitor in
binding pocket of COX-2 enzyme.
In the current study, friedelin was found to show mild activity against Grampositive bacteria B. cereus and S. aureus however did not show activity against Gramnegative bacteria E. coli and also with fungi species involved in the study C. albicans and
A. niger.
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CHAPTER 5

CONCLUSION
Since ancient times, the lifeline of human being has been mostly dependent on
nature, it has imparted several resources, including valuable medicines especially from
plants for the remedy of several diseases. Different human culture has been closely
associated with nature as their customs and rituals, and they have had strong impact on
human civilization through nature and natural products. Despite plethora of studies on
natural products, there are a large number of plant species, possessing healing properties,
which are yet to be explored.
From plant species Drypetes lasiogyna, we isolated and characterized new
compound 5α-dammar-20-ene-24,25-diol-3-yl caffeate. In addition, we found 5αdammar-20-ene-3β,24,25-triol to have possessed excellent cytotoxic activity against
human cancer cell lines namely 5637, MCF-7, MDA-MB-231, with killing rate of 100%,
89.65% and 97.77%, respectively.
Likewise, from another plant species Tabebuia bahamensis, taraxeryl acetate
extracted from acetone bark extract was shown to have good activity against C. albicans.
Consistent findings have been reported to possess antimicrobial activity against various
microbial species too. Moreover, Tabebuia bahamensis have also been reported to exhibit
significant cytotoxic, alongside antileishmanial and aphrodisiac activity, owing toits
pharmacologically active compound including ursolic acid, lapachol and other
components.
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5α-dammar-20-ene-3β, 24,25-triol possesses potent cytotoxic activity. It is in
accordance with the docking analysis. The protein-ligand interaction with the most
exothermic docking energy was the DNA binding site of topoisomerase II, suggesting
that this may be an important target in the cytotoxic activity of aglaitriol. 5α-dammar-20ene-24,25-diol-3-yl caffeate being a new compound further biological activity tests
should be carried out.
Thus, the tropical rainforests of Paluma, Northern Queensland Australia and
Abaco Island, Bahamas, being the house of a numerous, and diversified plant species
containing pharmacologically active compounds, has a remarkable potential for the
natural product drug discovery. Henceforth, further research is necessitated to procure
such valuable compounds for the benefit of humankind.
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